Pain in joint

JOINTPAIN

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M25.5 Hospital discharge: ICD-8 — 7873 Cause of death: ICD-10 — M25.5 Cause of death: ICD-8 — 7873 2 out of 7 registries used, show all original rules.	40721
4. Check minimum number of events None	40721
5. Include endpoints None	40721
6. Filter based on genotype QC (FinnGen only)	40721

Control definitions (FinnGen only)

Control exclude: PAIN

Extra metadata

First used in FinnGen datafreeze: DF3
Parent code in ICD-10: M25
Name in latin: Arthralgia

NAME	JOINTPAIN
CONTROL_EXCLUDE	PAIN
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M255
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	7873
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M255
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	7873
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Pain in joint based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	261287	159755	100459
Only index persons	249185	153957	95228
Unadjusted period prevalence (%)
Whole population	3.88	4.58	2.81
Only index persons	4.89	5.66	3.64
Median age at first event (years)
Whole population	43.78	44.93	41.99
Only index persons	43.97	45.00	42.31

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	40721	28124	12597
Unadjusted period prevalence (%)	8.34	9.59	5.55
Median age at first event (years)	48.41	46.99	51.57

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
19252: Matched controls
153296

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M02AA07

ATC

piroxicam; topical

2.1

323.0

6005

26726

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

4.0

323.0

1909

4080

M54.2

ICD-10 Finland

Cervicalgia

6.1

323.0

1201

1664

M03BC51

ATC

orphenadrine, combinations; systemic

2.4

323.0

4491

17021

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

6.3

323.0

1002

1333

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.9

323.0

4911

16127

M79.7

ICD-10 Finland

Fibromyalgia

25.3

323.0

541

175

A01

ICPC

Pain general/multiple sites

4.2

323.0

1453

2912

WX320

NOMESCO Finland

Spinalanesthesy

2.3

323.0

4153

16170

P01AB01

ATC

metronidazole; oral, rectal

2.2

323.0

5785

24755

P01BA02

ATC

hydroxychloroquine; oral

4.4

323.0

1714

3324

J01FA10

ATC

azithromycin; systemic

1.9

323.0

10099

57108

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.9

323.0

2346

7011

ZXE10

NOMESCO Finland

More than one and less than three hours

2.1

323.0

6096

27881

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

10.4

323.0

6593

7329

WX110

NOMESCO Finland

Local anesthesy

1.9

323.0

12635

76418

R51.80

ICD-10 Finland

Headache

11.2

323.0

2944

2425

SAA01

NOMESCO Finland

Simple examination of mouth

2.0

323.0

12820

77298

J01DB01

ATC

cefalexin; oral

2.5

323.0

15351

94059

A02BC02

ATC

pantoprazole; systemic

2.9

323.0

11763

54117

78739

ICD-8 Finland

Symptoms referable to limbs and joints, Arthralgia alia sive NUD

+∞

323.0

386

R52.2

ICD-10 Finland

Other chronic pain

13.9

323.0

661

392

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

4.4

323.0

1661

3218

WX408

NOMESCO Finland

General anesthesy, balanced

2.2

323.0

4711

19984

M01AC06

ATC

meloxicam; systemic, rectal

2.6

323.0

6319

24358

R07.4

ICD-10 Finland

Chest pain, unspecified

2.9

323.0

4941

16381

ZXD10

NOMESCO Finland

Scheduled procedure

2.1

323.0

6601

30177

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

6.0

323.0

1479

2113

L13

ICPC

Hip symptom/complaint

3.0

323.0

2720

8019

L17

ICPC

Foot/toe symptom/complaint

2.5

323.0

4697

17759

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.4

323.0

5104

19867

M54.4

ICD-10 Finland

Lumbago with sciatica

6.2

323.0

3117

4627

N02BE01

ATC

paracetamol; systemic, rectal

3.6

323.0

16310

92936

L12

ICPC

Hand/finger symptom/complaint

2.8

323.0

2828

8974

N06AX21

ATC

duloxetine; oral

5.3

323.0

1973

3228

A02BC05

ATC

esomeprazole; systemic

2.6

323.0

6886

26813

M01AX05

ATC

glucosamine; oral

2.7

323.0

3578

11978

L08

ICPC

Shoulder symptom/complaint

2.8

323.0

3590

11525

X59

ICD-10 Finland

Exposure to unspecified factor

2.6

323.0

3908

13772

M03BC01

ATC

orphenadrine (citrate); systemic

3.1

323.0

4058

12096

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

+∞

323.0

485

A06AC01

ATC

ispaghula (psylla seeds); oral

2.5

323.0

3652

13114

M13.9

ICD-10 Finland

Arthritis, unspecified

5.0

323.0

1894

3271

M54.5

ICD-10 Finland

Low back pain

4.5

323.0

6709

16168

X58

ICD-10 Finland

Exposure to other specified factors

2.6

323.0

2901

9912

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

7.1

323.0

2016

2479

R4110

NOMESCO Finland

Physiotherapy

2.4

323.0

5057

19656

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

3.8

323.0

2006

4507

M48.0

ICD-10 Finland

Spinal stenosis

4.4

323.0

2250

4453

ZXA05

NOMESCO Finland

Left side

2.3

323.0

4646

18507

M03BX02

ATC

tizanidine; oral

2.7

323.0

11076

51048

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

8.1

323.0

1565

1656

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.2

323.0

7921

36480

G56.0

ICD-10 Finland

Carpal tunnel syndrome

3.5

323.0

2251

5626

R52.9

ICD-10 Finland

Pain, unspecified

5.3

323.0

1623

2640

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

3.7

323.0

2001

4717

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

3.0

323.0

9139

35694

M75.1

ICD-10 Finland

Rotator cuff syndrome

3.2

323.0

4721

14031

M01AB05

ATC

diclofenac; systemic, rectal

2.5

323.0

12166

61763

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

8.8

323.0

1309

1262

M01AE01

ATC

ibuprofen; systemic, rectal

2.6

323.0

16658

109491

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

4.1

323.0

2792

6042

L15

ICPC

Knee symptom/complaint

3.1

323.0

4489

13842

A02BC03

ATC

lansoprazole; oral

2.6

323.0

4738

17199

M01AX17

ATC

nimesulide; oral

2.4

323.0

3936

14944

J01DA01

ATC

[U] cefalexin; systemic

1.8

323.0

10479

60901

M01AH05

ATC

etoricoxib; oral

3.2

323.0

11550

48851

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

4.7

323.0

2733

5224

N03AX16

ATC

pregabalin; oral

4.9

323.0

4914

9982

Z01.8

ICD-10 Finland

Other specified special examinations

2.4

323.0

3718

13806

A07EC01

ATC

sulfasalazine; oral, rectal

3.6

323.0

1674

3971

M54.9

ICD-10 Finland

Dorsalgia, unspecified

7.0

323.0

2121

2651

N06AA09

ATC

amitriptyline; systemic

4.7

323.0

1661

3009

M70.6

ICD-10 Finland

Trochanteric bursitis

4.0

323.0

1765

3773

M01AE03

ATC

ketoprofen; systemic, rectal

2.1

323.0

6103

27830

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.9

323.0

9584

53189

M25.5

ICD-10 Finland

Pain in joint

641.7

323.0

18897

11889

M79.6

ICD-10 Finland

Pain in limb

5.2

323.0

7741

17512

ZXA00

NOMESCO Finland

Right side

2.4

323.0

5012

19810

M79.1

ICD-10 Finland

Myalgia

4.3

323.0

2370

4839

UJF32

NOMESCO Finland

Coloscopy

2.5

323.0

4084

14827

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.8

323.0

8985

49239

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

3.0

323.0

2746

7934

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

5.7

323.0

1938

2941

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

8.8

323.0

2240

2268

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.1

323.0

7833

38106

M17.1

ICD-10 Finland

Other primary gonarthrosis

3.3

323.0

4191

12007

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

3.4

323.0

2306

5838

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

3.8

323.0

2808

6620

Z3226

NOMESCO Finland

Physiotherapist

2.8

323.0

3649

11970

ZXE00

NOMESCO Finland

One hour or less

2.0

323.0

6838

32849

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

323.0

7767

39975

R53

ICD-10 Finland

Malaise and fatigue

2.5

323.0

3423

12376

L03

ICPC

Low back symptom/complaint

3.2

323.0

4696

14102

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

6.1

323.0

3538

5450

N02AX02

ATC

tramadol; systemic, rectal

3.7

323.0

8673

27931

N03AX12

ATC

gabapentin; oral

5.7

323.0

3244

5277

L01

ICPC

Neck symptom/complaint

2.9

323.0

2304

6882

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

5.5

323.0

1737

2736

J01AA02

ATC

doxycycline; systemic

2.2

323.0

13228

76740

M01AE02

ATC

naproxen; oral, rectal

2.4

323.0

10771

52944

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

5.0

323.0

2321

4127

M54.3

ICD-10 Finland

Sciatica

8.1

323.0

945

966

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.9

323.0

8538

45149

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.6

323.0

3510

12085

R10.1

ICD-10 Finland

Pain localized to upper abdomen

6.1

323.0

2633

3851

G44.2

ICD-10 Finland

Tension-type headache

4.1

323.0

2232

4722

R01AD09

ATC

mometasone; nasal

2.0

323.0

7370

36683

R42

ICD-10 Finland

Dizziness and giddiness

2.5

323.0

3529

12755

R06.0

ICD-10 Finland

Dyspnoea

2.6

323.0

4364

15720

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.1

323.0

5347

23292

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

5.4

323.0

1111

1728

N02AJ06

ATC

codeine and paracetamol; systemic

3.0

323.0

7663

27971

J01CA04

ATC

amoxicillin; systemic

2.0

323.0

14902

96735

A02BC01

ATC

omeprazole; systemic

2.4

323.0

4582

17528

H02AB06

ATC

prednisolone; systemic

2.6

323.0

8825

37321

N06AX11

ATC

mirtazapine; oral

2.3

323.0

5331

21704

M19.0

ICD-10 Finland

Primary arthrosis of other joints

4.6

323.0

2070

3907

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.1

323.0

4709

20120

R03AC02

ATC

salbutamol; inhalant

2.3

323.0

9395

45442

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

4.2

323.0

1732

3495

S18

ICPC

Laceration/cut

2.0

323.0

7500

37351

M79.0

ICD-10 Finland

Rheumatism, unspecified

58.1

323.0

566

M01AH01

ATC

celecoxib; oral (coxibs)

3.0

323.0

3153

9314

D01

ICPC

Abdominal pain/cramps general

3.2

321.1

1948

5227

R06AE07

ATC

cetirizine; oral

1.9

317.0

7263

37538

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.5

310.2

2954

10475

J02AC01

ATC

fluconazole; systemic

2.0

308.3

4811

21468

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.5

306.5

2882

10144

M54.6

ICD-10 Finland

Pain in thoracic spine

5.1

305.9

1068

1738

M01AH02

ATC

rofecoxib; oral

2.9

304.8

2140

6334

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

+∞

303.8

318

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

4.0

301.4

1352

2835

J01FA06

ATC

roxithromycin; oral

1.9

301.0

6217

30826

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

7.6

297.5

764

828

R74

ICPC

Upper respiratory infection acute

2.0

296.6

4977

22801

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.1

294.4

1833

4995

WX002

NOMESCO Finland

Sedation and analgesia

2.2

294.0

3469

13661

A02BA02

ATC

ranitidine; systemic

2.4

293.0

2893

10428

L28

ICPC

Limited function/disability (L)

2.6

292.8

2547

8570

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.4

289.7

3048

11344

J45.9

ICD-10 Finland

Asthma, unspecified

2.4

288.6

2887

10467

NF1AA

NOMESCO Finland

Hip X-ray examination

3.3

288.6

1630

4132

B01AB05

ATC

enoxaparin; parenteral

2.0

288.6

4797

21854

N06AX16

ATC

venlafaxine; oral

2.8

285.7

2123

6499

Z2221

NOMESCO Finland

Medical doctor

2.0

285.2

4648

20996

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.3

283.5

3287

12811

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.6

281.6

2480

8389

M53.1

ICD-10 Finland

Cervicobrachial syndrome

3.3

281.5

1599

4068

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

5.0

281.4

996

1643

L16

ICPC

Ankle symptom/complaint

2.9

279.1

2002

5990

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.7

279.0

2243

7196

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

3.0

275.0

1813

5128

N05CF01

ATC

zopiclone; oral

2.0

274.7

4802

22229

R07.3

ICD-10 Finland

Other chest pain

3.3

273.8

1579

4061

L02

ICPC

Back symptom/complaint

3.2

272.0

1622

4274

J01FF01

ATC

clindamycin; systemic

2.0

271.3

4496

20373

M54

ICD-10 Finland

Dorsalgia

2.8

264.1

1898

5674

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.9

262.2

4915

23280

J01MA02

ATC

ciprofloxacin; systemic

1.8

261.0

6065

30953

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

8.0

260.0

644

658

R05

ICPC

Cough

2.1

258.9

3719

15866

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.7

257.6

1272

2889

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.6

257.3

2145

7009

N01

ICPC

Headache

2.7

256.8

2058

6572

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.8

254.5

5858

29745

M54.1

ICD-10 Finland

Radiculopathy

9.8

254.3

562

471

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

3.5

252.9

1336

3205

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

8.0

251.8

626

643

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.3

250.2

1440

3689

J01FA09

ATC

clarithromycin; systemic

1.9

249.2

4921

23672

SPAT1263

SPAT

Sampling

1.7

248.9

7387

40572

Z3231

NOMESCO Finland

Registered nurse

1.9

248.9

4671

22059

D06

ICPC

Abdominal pain localized other

3.5

247.8

1314

3160

SAA02

NOMESCO Finland

Basic examination of mouth

1.7

246.3

11523

72089

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.3

245.2

2651

9925

R05

ICD-10 Finland

Cough

2.2

242.8

3113

12609

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

242.7

3419

14420

N02AA05

ATC

oxycodone; systemic

2.5

242.4

2188

7458

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.8

242.2

1764

5303

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.7

241.9

1947

6218

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

7.5

241.8

626

685

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.7

241.2

9297

54925

Z71.8

ICD-10 Finland

Other specified counselling

2.0

241.2

4056

18356

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

2.4

241.0

2425

8753

M23.8

ICD-10 Finland

Other internal derangements of knee

5.0

240.8

848

1387

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

3.0

240.5

1591

4493

L86

ICPC

Back syndrome with radiating pain

4.6

235.9

913

1652

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.1

235.8

1500

4122

H02AB07

ATC

prednisone; oral

2.4

235.2

2243

7866

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.3

234.9

1345

3427

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

3.5

233.5

1231

2943

R01AD08

ATC

fluticasone; nasal

1.9

233.4

4398

20722

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

2.0

233.2

3936

17806

K30

ICD-10 Finland

Functional dyspepsia

3.1

232.1

1456

3961

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

3.4

231.0

1245

3028

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.7

228.9

6741

36673

K02.1

ICD-10 Finland

Caries of dentine

1.6

228.8

10045

61145

AA1AD

NOMESCO Finland

CT of head and brain

2.0

228.2

3657

16198

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.4

227.0

2220

7880

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.6

226.3

9606

57865

M02AA10

ATC

ketoprofen; topical

2.3

226.0

2456

9187

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

7.4

222.2

577

634

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

26.2

222.1

334

103

R02

ICPC

Shortness of breath/dyspnoea

2.5

221.8

2001

6799

N05BA04

ATC

oxazepam; oral

2.0

221.5

3554

15723

G43.9

ICD-10 Finland

Migraine, unspecified

4.7

220.4

825

1440

N05AH04

ATC

quetiapine; oral

2.2

219.5

2715

10774

R03DC03

ATC

montelukast; oral

2.3

219.5

2351

8725

L20

ICPC

Joint symptom/complaint NOS

5.2

214.6

739

1177

ZXD20

NOMESCO Finland

Day surgery

2.4

214.6

2167

7805

R51

ICD-10 Finland

Headache

4.6

212.9

815

1456

M16.1

ICD-10 Finland

Other primary coxarthrosis

2.5

211.6

1906

6463

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

3.0

209.7

1386

3898

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

2.0

209.1

3155

13592

R21

ICPC

Throat symptom/complaint

1.9

209.0

3565

16099

L11

ICPC

Wrist symptom/complaint

2.9

208.6

1451

4220

L29

ICPC

Musculoskeletal sympt/complt other

3.1

208.0

1313

3578

R60.0

ICD-10 Finland

Localized oedema

2.6

207.4

1759

5765

SPAT1153

SPAT

Removal of sutures

1.8

207.0

5140

26361

R01AD12

ATC

fluticasone furoate; nasal

1.8

206.1

4475

21981

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.7

205.5

1630

5137

D11

ICPC

Diarrhoea

2.4

205.3

1917

6620

H04.10

ICD-10 Finland

Dry eye syndrome

2.9

205.0

1389

3969

C07AB07

ATC

bisoprolol; oral

1.6

204.0

7171

40639

H02AB04

ATC

methylprednisolone; systemic

2.3

203.4

2138

7841

M01AB55

ATC

diclofenac, combinations; oral

3.4

203.1

1089

2631

D07AC01

ATC

betamethasone; topical

1.7

202.9

5411

28328

R06AX27

ATC

desloratadine; oral

1.8

202.8

4130

19835

ZXD05

NOMESCO Finland

Urgent procedure

1.8

201.7

4756

23961

Z01.2

ICD-10 Finland

Dental examination

1.6

200.5

6924

38998

XF400

NOMESCO Finland

ECG with 12 standard connections

2.1

199.6

2684

11005

K07.60

ICD-10 Finland

Snapping jaw

5.5

197.7

647

970

M22.4

ICD-10 Finland

Chondromalacia patellae

5.4

196.8

652

992

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

3.1

196.3

1193

3162

E0000UV

ATC

1.7

196.2

6448

35769

M47.82

ICD-10 Finland

Other spondylosis, cervical region

5.7

195.4

614

876

A11

ICPC

Chest pain NOS

3.0

194.1

1267

3527

M47.9

ICD-10 Finland

Spondylosis, unspecified

6.2

193.6

568

742

J01CA08

ATC

pivmecillinam; oral

1.8

193.2

4447

22180

M54.8

ICD-10 Finland

Other dorsalgia

5.5

193.1

631

944

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.8

193.0

1407

4206

KMAK

NOMESCO Finland

1.6

192.5

8593

51579

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

6.1

192.3

575

770

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

6.6

192.1

541

668

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

4.3

191.8

782

1486

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.5

190.8

1658

5495

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.1

189.3

2644

10995

R20.2

ICD-10 Finland

Paraesthesia of skin

3.4

188.9

1008

2423

WX290

NOMESCO Finland

Other blockade of nerve

1.6

187.4

7637

44690

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.0

187.3

2799

11959

N06AB04

ATC

citalopram; systemic

2.0

187.2

2885

12476

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

6.9

186.6

507

595

ACC51

NOMESCO Finland

Release of median nerve

3.3

186.4

1063

2688

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.8

185.6

1365

4102

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.5

185.1

1613

5352

S06.0

ICD-10 Finland

Concussion

2.4

184.8

1815

6415

N17

ICPC

Vertigo/dizziness

2.4

184.8

1779

6225

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

3.5

184.8

979

2340

R10.0

ICD-10 Finland

Acute abdomen

9.0

183.2

423

383

N06AB10

ATC

escitalopram; oral

2.0

181.6

2951

13008

SPAT1283

SPAT

Restricted health certificate

1.9

181.0

3011

13388

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

16.1

181.0

318

160

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

7.2

178.5

472

532

M77.1

ICD-10 Finland

Lateral epicondylitis

3.2

177.5

1057

2755

UJF30

NOMESCO Finland

Ileoscopy through colon

2.6

177.5

1441

4590

F51.0

ICD-10 Finland

Nonorganic insomnia

2.3

176.9

1911

7073

H01

ICPC

Ear pain/earache

2.3

176.5

1835

6665

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.3

176.0

1808

6529

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.7

176.0

857

1911

R05FA02

ATC

opium derivatives and expectorants; systemic

1.6

175.7

6166

34546

M53.0

ICD-10 Finland

Cervicocranial syndrome

3.0

175.6

1135

3133

R03BA05

ATC

fluticasone; inhalant

2.0

175.5

2803

12259

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

7.2

174.9

462

520

R11

ICD-10 Finland

Nausea and vomiting

2.9

174.1

1220

3552

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

11.0

174.0

360

265

J01CE02

ATC

phenoxymethylpenicillin; oral

1.5

172.4

12196

80802

R52.0

ICD-10 Finland

Acute pain

6.8

171.7

474

569

WZA90

NOMESCO Finland

Other doctors statement

1.8

171.6

4011

19983

R01BA52

ATC

pseudoephedrine, combinations; oral

1.8

171.4

3886

19173

L88

ICPC

Rheumatoid/seropositive arthritis

4.4

170.9

684

1275

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.5

170.8

1543

5211

D02

ICPC

Abdominal pain epigastric

3.6

170.4

852

1941

C07AA05

ATC

propranolol; systemic

2.0

169.9

2714

11856

A04

ICPC

Weakness/tiredness general

2.1

169.8

2158

8590

SPAT1301

SPAT

No procedures

1.7

169.7

5232

28251

N30.0

ICD-10 Finland

Acute cystitis

2.2

168.8

1890

7106

R03BA02

ATC

budesonide; inhalant

2.0

168.5

2626

11362

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.8

167.7

3721

18219

N05BA01

ATC

diazepam; systemic, rectal

2.2

167.6

1931

7356

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

7.7

166.3

421

444

N05CF02

ATC

zolpidem; oral

2.0

166.0

2373

9916

SPAT1310

SPAT

Counselling related to known health issue

1.6

164.9

5433

29813

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

3.3

164.9

943

2384

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.6

164.8

6151

34869

G47.3

ICD-10 Finland

Sleep apnoea

1.8

164.5

3419

16372

R50.9

ICD-10 Finland

Fever, unspecified

2.1

163.9

2241

9193

J01MA12

ATC

levofloxacin; systemic

1.9

163.9

2693

11876

R03AK07

ATC

formoterol and budesonide; inhalant

1.9

163.8

2711

11987

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.9

163.0

2654

11660

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

162.3

3323

15826

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.7

161.4

1220

3718

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

3.8

161.3

752

1614

S80.0

ICD-10 Finland

Contusion of knee

2.9

160.5

1094

3125

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

4.2

160.5

664

1278

ND1AA

NOMESCO Finland

Wrist X-ray examination

3.0

159.8

1022

2797

M77.4

ICD-10 Finland

Metatarsalgia

3.6

159.5

797

1814

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

2.6

158.6

1293

4117

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.6

158.1

5344

29454

H57.1

ICD-10 Finland

Ocular pain

6.4

158.0

453

573

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

8.8

157.8

368

339

A03

ICPC

Fever

1.9

157.5

2759

12440

R4120

NOMESCO Finland

Occupational therapy

2.8

157.2

1117

3273

J01EA01

ATC

trimethoprim; systemic

1.8

157.1

3056

14290

S83.2

ICD-10 Finland

Tear of meniscus, current

2.5

156.8

1370

4534

M35.7

ICD-10 Finland

Hypermobility syndrome

17.2

156.4

268

126

M19.9

ICD-10 Finland

Arthrosis, unspecified

4.3

155.1

628

1183

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

3.2

153.6

887

2257

R05FB02

ATC

cough suppressants and expectorants

1.6

152.5

5189

28592

A02BC04

ATC

rabeprazole; oral

2.7

151.3

1130

3414

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.6

151.2

4617

24710

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

150.5

6488

37878

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

150.4

6491

37901

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.1

149.2

1874

7398

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

5.6

148.9

476

693

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

4.0

148.5

659

1353

ND1BG

NOMESCO Finland

Wrist and hand MRI examination with high intensity magnet

12.3

148.5

291

191

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

2.4

147.9

1424

4959

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.8

147.1

1043

3051

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.8

146.3

1080

3239

XF402

NOMESCO Finland

ECG with work load test

2.2

145.8

1778

6923

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

3.3

145.7

816

2029

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

6.1

144.6

429

568

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

144.6

2852

13360

M43.1

ICD-10 Finland

Spondylolisthesis

4.6

144.1

545

958

J45

ICD-10 Finland

Asthma

2.4

144.1

1428

5043

R03BA01

ATC

beclometasone; inhalant

2.1

143.8

1945

7916

ZXA10

NOMESCO Finland

Bilateral

1.8

143.8

2838

13296

L14

ICPC

Leg/thigh symptom/complaint

2.6

143.6

1171

3723

UKC02

NOMESCO Finland

Cystoscopy

1.9

143.6

2385

10515

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.3

143.2

1439

5115

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

4.4

142.3

561

1029

72880

ICD-8 Finland

Vertebrogenic pain syndrome, Radicula syndrome of lower limbs

+∞

141.2

148

J20

ICD-10 Finland

Acute bronchitis

2.4

140.6

1369

4790

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

2.7

140.5

1091

3372

U02

ICPC

Urinary frequency/urgency

2.1

140.3

1822

7285

N04BC05

ATC

pramipexole; oral

2.8

140.3

1034

3097

N03AE01

ATC

clonazepam; systemic

3.1

139.4

843

2216

D07AB02

ATC

hydrocortisone butyrate; topical

1.6

139.3

4169

22106

SPAT1260

SPAT

Consultation of another employee

1.8

138.3

2816

13310

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.2

137.4

1586

6017

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

4.5

137.4

533

962

A98

ICPC

Health maint/preventive medicine

2.0

137.3

17994

134434

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

5.7

137.1

428

605

R09

ICPC

Sinus symptom/complaint

2.7

137.1

1074

3336

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.4

136.8

1309

4535

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.9

136.5

912

2564

SPAT1254

SPAT

Administration of medicine

1.9

136.5

2493

11355

S29

ICPC

Skin symptom/complaint other

1.8

135.1

2614

12141

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.3

134.2

1350

4796

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

5.2

134.0

452

701

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

4.4

133.3

525

962

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

3.4

133.2

718

1733

R96

ICPC

Asthma

2.4

132.5

1257

4333

R51.81

ICD-10 Finland

Facial pain NOS

11.4

132.4

269

191

72870

ICD-8 Finland

Vertebrogenic pain syndrome, Lumbalgia

+∞

131.6

138

SPAT1216

SPAT

Assessment of functional ability

1.9

131.5

2214

9786

79199

ICD-8 Finland

Headache

+∞

130.6

137

R12

ICD-10 Finland

Heartburn

2.7

130.4

1002

3073

K59.09

ICD-10 Finland

Constipation, unspecified

3.1

130.4

809

2164

L04

ICPC

Chest symptom/complaint

2.9

130.2

897

2572

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.6

130.1

3940

20900

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

129.8

5301

30295

R10.2

ICD-10 Finland

Pelvic and perineal pain

9.0

129.6

298

268

A06AD11

ATC

lactulose; oral

2.0

129.4

1866

7773

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.8

129.3

935

2764

S01GX01

ATC

cromoglicic acid; ophthalmic

1.8

129.1

2748

13150

C03CA01

ATC

furosemide; systemic

1.6

128.1

3824

20190

A03FA01

ATC

metoclopramide; systemic, rectal

1.8

127.9

2488

11555

M15

ICD-10 Finland

Polyarthrosis

3.4

127.8

696

1693

7245A

ICD-9 Finland

Other and unspecified disorders of back, Backache, unspecified

+∞

127.8

134

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

6.9

127.4

345

403

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

2.2

126.9

1391

5147

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.5

126.1

1117

3713

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.6

126.0

3904

20808

J31.0

ICD-10 Finland

Chronic rhinitis

2.4

124.6

1135

3827

R00.2

ICD-10 Finland

Palpitations

2.7

124.4

950

2902

P03

ICPC

Feeling depressed

2.1

124.3

1514

5875

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

3.8

124.0

581

1250

Z50.1

ICD-10 Finland

Other physical therapy

2.9

124.0

829

2331

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

5.1

123.5

426

678

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

3.6

123.4

624

1431

D07AD01

ATC

clobetasol; topical

1.9

123.3

2168

9715

-1

NOMESCO Finland

1.5

122.9

5681

33301

A03FA02

ATC

cisapride; oral, rectal

2.6

122.8

997

3156

N06AB06

ATC

sertraline; oral

2.1

122.8

1527

5975

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.4

122.7

1132

3843

M01AG02

ATC

tolfenamic acid; oral, rectal

2.1

122.2

1549

6111

H53.1

ICD-10 Finland

Subjective visual disturbances

2.7

122.2

903

2702

M09AX01

ATC

hyaluronic acid; parenteral

2.9

122.1

816

2292

W19

ICD-10 Finland

Unspecified fall

2.1

121.6

1534

6040

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.6

121.2

980

3095

G56.2

ICD-10 Finland

Lesion of ulnar nerve

3.8

121.0

559

1188

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

3.0

120.9

770

2095

L05

ICPC

Flank/axilla symptom/complaint

2.9

120.9

830

2372

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

3.7

120.9

586

1298

W00

ICD-10 Finland

Fall on same level involving ice and snow

2.0

120.6

1664

6801

M01AX01

ATC

nabumetone; oral

3.4

120.4

639

1523

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.0

120.3

1810

7654

G54.0

ICD-10 Finland

Brachial plexus disorders

6.3

120.1

346

441

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

120.0

1904

8216

Z00.0

ICD-10 Finland

General medical examination

1.7

119.2

2965

14840

H02BX01

ATC

methylprednisolone, combinations; systemic

2.8

118.4

822

2367

H03AA01

ATC

levothyroxine sodium; systemic

1.7

118.3

2733

13379

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.5

118.3

999

3232

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

4.2

117.8

488

939

SPAT1240

SPAT

Therapeutic discussion

2.0

116.8

1730

7268

R03AC03

ATC

terbutaline; inhalant

1.9

116.7

1930

8449

R07.0

ICD-10 Finland

Pain in throat

2.6

116.6

936

2943

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

5.8

116.5

358

496

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.3

116.5

1214

4380

L09

ICPC

Arm symptom/complaint

3.1

116.4

691

1790

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.4

116.2

1081

3682

M19.8

ICD-10 Finland

Other specified arthrosis

4.0

116.0

512

1045

XA402

NOMESCO Finland

ENMG

5.3

115.8

384

584

L84

ICPC

Back syndrome without radiat pain

3.3

115.6

649

1614

L90

ICPC

Osteoarthrosis of knee

2.7

115.3

897

2768

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

4.3

115.2

466

876

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.9

115.2

764

2135

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.7

115.2

863

2605

R13

ICD-10 Finland

Dysphagia

2.7

115.1

876

2668

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.4

114.7

1104

3826

M35.3

ICD-10 Finland

Polymyalgia rheumatica

3.3

114.4

639

1582

R35

ICD-10 Finland

Polyuria

2.5

114.3

984

3216

A28

ICPC

Limited function/disability NOS

1.9

113.0

2010

9027

JN3AD

NOMESCO Finland

Abdominal CT examination

2.5

113.0

948

3054

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

3.4

113.0

610

1473

A03CA02

ATC

clidinium and psycholeptics; oral

2.9

113.0

743

2065

ND1CG

NOMESCO Finland

Wrist and hand extensive MRI examination with high intensity magnet

10.3

112.6

240

188

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

2.6

112.1

885

2755

EBA00

NOMESCO Finland

Extraction of tooth

1.5

111.9

5642

33537

N06AB03

ATC

fluoxetine; oral

2.0

111.6

1611

6694

M67.4

ICD-10 Finland

Ganglion

2.6

111.5

907

2870

NG1DA

NOMESCO Finland

X-ray of knees

5.6

111.1

353

510

UJD02

NOMESCO Finland

Gastroscopy

3.2

111.0

633

1592

XQ800

NOMESCO Finland

Prick test

2.4

110.5

1050

3616

J05AB01

ATC

aciclovir; systemic

1.7

110.3

2722

13562

P06

ICPC

Sleep disturbance

2.1

109.2

1443

5783

R03BA08

ATC

ciclesonide; inhalant

2.3

108.8

1078

3788

K08.80

ICD-10 Finland

Toothache NOS

2.4

108.7

1057

3681

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

3.2

108.1

613

1535

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

7.8

107.9

270

280

N06AA10

ATC

nortriptyline; systemic

7.0

107.8

290

336

N03AX09

ATC

lamotrigine; oral

3.0

107.7

682

1846

R5599

NOMESCO Finland

Other rehabilitation service

4.1

107.2

458

907

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.1

107.1

1419

5692

NBG00

NOMESCO Finland

Plastic operation on acromioclavicular joint

5.6

107.0

337

482

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

4.4

106.9

419

764

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

3.1

106.8

637

1655

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.6

106.8

3900

21526

R52.1

ICD-10 Finland

Chronic intractable pain

66.7

106.5

133

NG2AA

NOMESCO Finland

Patella X-ray examination

3.8

106.5

490

1038

R06AX13

ATC

loratadine; oral

1.8

106.4

2144

10029

NH3EA

NOMESCO Finland

Feet X-ray examination with load

4.8

105.9

388

660

D07AC13

ATC

mometasone; topical

1.5

105.7

4164

23383

M50.3

ICD-10 Finland

Other cervical disc degeneration

5.6

105.6

334

480

T78.4

ICD-10 Finland

Allergy, unspecified

3.0

105.5

667

1804

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.2

105.4

1221

4620

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.0

105.4

666

1801

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

+∞

104.9

110

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

7.2

104.6

274

305

E66.01

ICD-10 Finland

Obesity due to excess calories

2.4

104.5

1006

3484

A01AB09

ATC

miconazole; local oral

2.2

104.4

1158

4295

M01AC01

ATC

piroxicam; systemic, rectal

1.9

104.3

1833

8184

R06AX22

ATC

ebastine; oral

1.8

104.3

2119

9935

G04BD12

ATC

mirabegron; oral

2.1

104.2

1353

5378

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.6

104.2

2933

15138

M25.2

ICD-10 Finland

Flail joint

7.2

104.0

274

308

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.3

103.8

1091

3947

A02BA04

ATC

nizatidine; systemic

2.4

103.6

969

3307

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

3.6

103.5

514

1161

SPAT1211

SPAT

Application of soft bandage

2.0

102.9

1465

6048

M10.9

ICD-10 Finland

Gout, unspecified

2.3

102.8

1053

3760

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.8

102.7

721

2089

D19

ICPC

Teeth/gum symptom/complaint

1.5

102.6

3935

21941

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

2.1

102.5

1234

4750

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

6.4

102.4

294

373

P01

ICPC

Feeling anxious/nervous/tense

1.9

101.8

1740

7688

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.4

101.6

533

1258

J01DA06

ATC

[U] cefuroxime; systemic

1.8

101.3

2037

9512

Z2446

NOMESCO Finland

Social worker

2.3

100.9

1044

3746

S89.9

ICD-10 Finland

Unspecified injury of lower leg

3.3

100.9

562

1389

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.0

100.4

1377

5597

U01

ICPC

Dysuria/painful urination

2.3

100.1

1035

3711

K35.9

ICD-10 Finland

Acute appendicitis, unspecified

2.4

100.1

949

3260

G50.0

ICD-10 Finland

Trigeminal neuralgia

16.9

99.8

171

G50.1

ICD-10 Finland

Atypical facial pain

12.8

99.6

191

120

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

3.9

99.5

447

927

S21

ICPC

Skin texture symptom/complaint

1.8

99.4

1868

8526

H92.0

ICD-10 Finland

Otalgia

2.8

99.1

716

2111

A29

ICPC

General symptom/complaint other

1.9

98.7

1574

6780

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.1

98.6

1186

4559

C05AA08

ATC

fluocortolone; rectal, topical

1.8

98.2

1826

8303

SPAT1229

SPAT

Assessment of need for aid

2.2

97.7

1058

3877

SPAT1312

SPAT

General health counselling

1.5

97.6

5305

31820

XF404

NOMESCO Finland

Ambulatory ECG

2.0

97.6

1406

5826

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.4

97.2

515

1225

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

6.2

96.4

283

370

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

4.2

96.3

403

783

C01DA14

ATC

isosorbide mononitrate; oral

1.8

96.2

1988

9355

K03.64

ICD-10 Finland

Dental calculus supragingival

1.5

96.1

4282

24631

NHF25

NOMESCO Finland

Operation for debridement of ankle joint, arthroscopic

6.8

95.6

260

306

WX402

NOMESCO Finland

General anaesthesia

1.7

95.6

2316

11433

L04AA13

ATC

leflunomide; oral

4.4

95.6

377

692

TQW40

NOMESCO Finland

Remowal of suture of skin

2.2

95.3

1080

4043

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.3

95.2

988

3548

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.8

95.2

1961

9215

D10

ICPC

Vomiting

2.3

95.0

938

3288

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

3.2

94.9

547

1384

K59.1

ICD-10 Finland

Functional diarrhoea

2.8

94.7

684

2014

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

4.1

94.6

404

800

M20.1

ICD-10 Finland

Hallux valgus (acquired)

2.4

94.6

908

3137

J45.1

ICD-10 Finland

Nonallergic asthma

2.2

94.4

1012

3690

A46

ICD-10 Finland

Erysipelas

1.7

94.3

2059

9851

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.7

94.3

2542

12932

M75.8

ICD-10 Finland

Other shoulder lesions

3.5

94.2

483

1120

SDA02

NOMESCO Finland

Parodonthologic therapy

1.5

94.1

4896

29060

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.4

93.9

887

3040

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.6

93.7

747

2335

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

93.7

3181

17174

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.3

93.7

931

3273

D09

ICPC

Nausea

2.6

93.5

744

2321

R06AE09

ATC

levocetirizine; oral

1.8

93.3

1987

9430

A06AC51

ATC

ispaghula, combinations; systemic

2.8

93.2

652

1882

A05

ICPC

Feeling ill

2.1

93.0

1154

4492

RF210

NOMESCO Finland

3.6

92.9

462

1045

ZX120

NOMESCO Finland

Intravenous

2.0

92.9

1268

5137

N05BA12

ATC

alprazolam; oral

2.0

92.8

1249

5033

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.1

92.7

1152

4489

XF600

NOMESCO Finland

Bloodpressure measurement

2.3

92.7

924

3253

M01AH03

ATC

valdecoxib; oral

2.4

92.5

850

2871

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.2

92.4

1064

4009

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

92.2

3209

17423

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.2

91.6

1081

4118

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

91.5

1921

9073

L18

ICPC

Muscle pain

3.0

91.5

577

1558

K10.3

ICD-10 Finland

Alveolitis of jaws

2.8

91.4

645

1872

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

91.3

2091

10144

S22.3

ICD-10 Finland

Fracture of rib

2.3

90.5

953

3444

S63.5

ICD-10 Finland

Sprain and strain of wrist

3.1

90.5

548

1437

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.7

90.3

2212

10942

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

2.1

90.1

1124

4386

M04AA01

ATC

allopurinol; systemic

1.8

90.0

1924

9136

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.0

89.9

568

1535

M05BA04

ATC

alendronic acid; oral

2.2

89.9

1033

3889

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.1

89.9

544

1426

M89.0

ICD-10 Finland

Algoneurodystrophy

16.0

89.3

156

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

2.7

89.2

668

2013

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

89.1

7728

50248

A07AA02

ATC

nystatin; oral

2.5

88.8

780

2571

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

88.8

2059

10019

F45.8

ICD-10 Finland

Other somatoform disorders

2.3

88.7

866

3016

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.9

88.6

600

1697

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

3.4

88.4

475

1142

R55

ICD-10 Finland

Syncope and collapse

1.9

88.2

1516

6697

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.8

88.0

610

1751

M65.3

ICD-10 Finland

Trigger finger

3.0

88.0

560

1520

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

3.0

88.0

565

1543

M76.6

ICD-10 Finland

Achilles tendinitis

2.6

87.9

683

2102

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.2

87.9

517

1330

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

87.4

3529

19798

K04.0

ICD-10 Finland

Pulpitis

1.9

87.4

1418

6133

NBG10

NOMESCO Finland

Acromioplastia

3.5

86.9

441

1014

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

3.7

86.9

412

896

H29

ICPC

Ear symptom/complaint other

1.9

86.8

1438

6266

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

4.3

86.7

347

646

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

9.5

86.4

191

161

SPAT1058

SPAT

PEF monitoring instruction

2.0

86.2

1175

4754

NF1DA

NOMESCO Finland

X-ray of hips

3.9

86.2

384

791

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

3.9

86.1

388

807

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.1

86.0

1017

3876

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

86.0

8367

55328

N05CD07

ATC

temazepam; oral

1.9

85.9

1522

6794

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

85.5

1907

9164

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.0

85.5

538

1450

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

2.7

85.5

620

1832

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.4

85.0

5319

32583

SPAT1097

SPAT

Recording of ECG

1.7

85.0

2015

9861

WX702

NOMESCO Finland

Supraglottic ventilation device

2.4

85.0

771

2586

SGA01

NOMESCO Finland

Tooth opening as first aid

1.7

84.6

2252

11385

R60.9

ICD-10 Finland

Oedema, unspecified

2.7

84.6

624

1860

A99

ICPC

Disease/condition unspecnature/site

2.0

84.5

1126

4513

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

84.4

2009

9843

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

2.7

84.4

639

1938

S70.0

ICD-10 Finland

Contusion of hip

3.1

84.4

507

1322

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.3

84.2

882

3176

C09CA06

ATC

candesartan; oral

1.6

83.9

2754

14702

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

83.8

2549

13351

SFA00

NOMESCO Finland

Small filling

1.7

83.8

1797

8534

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.2

83.6

898

3273

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

4.2

83.6

346

666

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.3

83.5

849

3015

D82

ICPC

Teeth/gum disease

1.4

83.3

5392

33205

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

4.1

83.3

352

691

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

6.3

83.0

240

308

M01AB08

ATC

etodolac; oral

2.2

83.0

909

3345

S63.6

ICD-10 Finland

Sprain and strain of finger(s)

2.8

83.0

581

1679

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.1

83.0

1004

3864

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.3

82.9

825

2898

7231A

ICD-9 Finland

Other disorders of cervical region, Cervicalgia

+∞

82.9

K59.0

ICD-10 Finland

Constipation

2.6

82.9

676

2139

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.2

82.7

949

3568

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

82.6

1559

7103

R07

ICPC

Sneezing/nasal congestion

2.1

82.6

980

3738

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

2.6

82.2

642

1982

B01AF01

ATC

rivaroxaban; oral

1.8

82.0

1665

7769

M70.7

ICD-10 Finland

Other bursitis of hip

4.4

81.7

322

591

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

8.8

81.7

189

173

NDA30

NOMESCO Finland

Exploration of joint of wrist or hand, arthroscopic

7.7

81.6

204

212

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.2

81.3

935

3517

M19.2

ICD-10 Finland

Other secondary arthrosis

6.0

81.3

244

329

E000001

ATC

1.5

81.3

3029

16653

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

4.3

81.2

330

624

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

3.7

80.8

389

857

J01MA06

ATC

norfloxacin; oral

1.8

80.4

1421

6328

F29

ICPC

Eye symptom/complaint other

2.0

80.3

1172

4867

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

4.5

80.3

309

554

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.4

80.2

768

2648

C10AA07

ATC

rosuvastatin; oral

1.5

79.6

3289

18501

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

79.6

1374

6071

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.8

79.3

1482

6727

WX200

NOMESCO Finland

Interscalenous plexus blockade

3.9

79.3

354

731

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.0

79.2

1117

4578

M77.9

ICD-10 Finland

Enthesopathy, unspecified

3.4

79.1

420

1001

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

79.1

1613

7533

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.4

79.0

748

2561

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

5.9

78.6

239

328

P76

ICPC

Depressive disorder

2.2

78.5

867

3200

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

32599

195189

1.87

315.66

5.0

4.3

mmol/l

2.8

0.53

30587

181237

(3012095) Magnesium [Moles/volume] in Serum or Plasma

6067

24147

1.79

313.21

3.2

3.5

mmol/l

0.8

2.65

5629

22579

(40761535) Cells panel - Urine sediment

3370

10996

2.13

309.25

3.8

3.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

5090

17944

2.02

307.65

1.8

1.6

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

9952

30462

2.59

307.65

1.9

1.7

mg/l

0.9

1.3

27.61

7422

23246

(3004616) Nuclear Ab [Presence] in Serum

1094

1535

4.83

307.65

1.4

1.3

—

(3026782) Osmolality of Urine

7363

27745

1.94

307.65

3.0

2.5

mosm/kgh2o

542.1

557.1

6.11

6323

23193

(3026008) Bacteria identified in Urine by Culture

10734

43585

1.89

307.65

3.3

2.6

—

(3048689) Calprotectin [Mass/mass] in Stool

6557

17813

2.74

307.65

2.5

ug/g

113.9

140.2

7.24

5187

14061

(3010813) Leukocytes [#/volume] in Blood

36284

224444

4.14

307.65

24.9

15.3

e9/l

6.8

6.6

21.49

35699

216654

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

7681

26755

2.14

307.65

4.0

3.2

ng/l

281.2

766.2

13.52

5430

20589

(3021589) Normoblasts [#/volume] in Blood

16713

79516

1.71

307.65

10.3

8.3

e9/l

0.0

0.25

13686

64890

(3031040) Bacteria [#/volume] in Urine by Automated count

24191

109069

2.34

307.65

5.1

3.5

e6/l

1459.0

1407.7

0.04

210

1597

(3013650) Neutrophils [#/volume] in Blood by Automated count

23913

96363

2.81

307.65

9.1

8.8

e9/l

4.0

1.41

21211

83390

(3032080) INR in Blood by Coagulation assay

14135

60376

1.89

307.65

7.8

7.9

inr

1.2

6.32

3805

17446

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

10545

36272

2.29

307.65

1.4

1.3

u/ml

1.5

2.0

2.53

2683

9962

(42870588) Differential panel, method unspecified - Blood

15849

55349

2.56

307.65

6.7

5.7

—

(3015736) pH of Urine

14827

63235

1.92

307.65

3.6

2.8

5.9

5.8

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

2166

3659

4.10

307.65

1.3

1.2

u/ml

33.4

40.0

0.41

105

247

(3004789) Transferrin [Mass/volume] in Serum or Plasma

5845

22148

1.89

307.65

2.6

2.4

g/l

2.4

2.3

5.86

5418

20455

(3042936) Bacteria identified in Isolate by Culture

6135

20755

2.15

307.65

2.2

1.9

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2249

4062

3.84

307.65

1.8

1.6

g/l

0.2

0.98

2134

3857

(3037522) Nuclear Ab [Titer] in Serum

9736

19170

4.20

307.65

1.5

1.3

titre

538.2

572.2

0.76

2104

3714

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

12185

21405

5.12

307.65

1.4

1.2

u/ml

12.2

13.8

0.88

4506

8579

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

7145

24295

2.17

307.65

2.8

2.5

e6/l

0.9

1.2

1.55

4035

13236

(3021960) Folate [Moles/volume] in Serum or Plasma

8728

34461

1.88

307.65

1.6

1.5

nmol/l

20.5

20.3

0.48

7612

29542

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

9370

38508

1.82

307.65

2.3

2.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

24635

133528

1.66

307.65

3.5

2.9

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

12343

23300

4.76

307.65

1.4

1.2

iu/ml

40.0

39.3

0.05

3812

7470

(3018095) Leukocytes [#/volume] in Urine

13867

54268

2.10

307.65

4.2

3.2

e6/l

63.9

107.7

8.73

9775

35641

(3029937) Albumin [Presence] in Urine by Test strip

9843

43586

1.67

307.65

4.6

3.2

estimate

0.0

0.02

3469

14671

(3028026) IgM [Mass/volume] in Serum or Plasma

2915

8660

2.33

307.65

1.7

1.8

g/l

1.2

1.3

2.00

2654

7927

(40760892) CBC W Ordered Manual Differential panel - Blood

9122

38691

1.74

307.65

5.0

4.1

—

(3044889) 12 lead EKG panel

23536

123747

1.71

307.65

3.8

3.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

12478

41700

2.48

307.65

2.8

2.2

u/l

56.0

59.7

7.88

11548

37952

(3044941) Cell count panel - Synovial fluid

1278

1890

4.60

307.65

1.5

1.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

6224

22294

2.02

307.65

1.9

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4352

14956

2.05

307.65

1.8

1.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

9918

36568

2.09

307.65

3.9

3.0

—

(3019150) Specific gravity of Urine by Refractometry

8464

34915

1.78

307.65

4.4

3.2

kg/l

1.0

0.40

1154

5397

(3019550) Sodium [Moles/volume] in Serum or Plasma

34234

191315

3.38

307.65

17.4

12.1

mmol/l

139.7

1.63

33654

185158

(3037467) Urinalysis macro (dipstick) panel - Urine

26328

117954

2.64

307.65

5.1

3.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

6793

26711

1.84

307.65

2.7

3.0

mmol/l

2.4

3.14

5846

23320

(3022948) Iron [Moles/volume] in Serum or Plasma

6384

24081

1.91

307.65

2.6

2.4

umol/l

16.8

13.6

0.49

5929

22369

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3998

8811

3.25

307.65

1.3

1.2

au/ml

42.4

50.1

0.84

118

435

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

32233

172247

2.82

307.65

5.6

4.1

mu/l

1.8

2.2

8.42

30256

158005

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

4310

9735

3.18

307.65

2.4

2.3

au/ml

22.1

22.8

0.12

221

703

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

12781

43029

2.47

307.65

2.2

2.0

u/l

165.8

236.8

13.28

12150

40200

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1979

3370

4.05

307.65

1.3

1.2

u/ml

6.5

7.7

0.19

195

348

(3002582) Erythrocytes [#/volume] in Urine

11727

44421

2.09

307.65

3.6

2.8

e6/l

58.5

113.2

3.10

9085

32650

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

35283

208200

3.47

307.65

12.7

8.2

u/l

26.6

26.7

0.65

34551

200122

(3023103) Potassium [Moles/volume] in Serum or Plasma

34293

192141

3.39

307.65

17.6

12.2

mmol/l

3.9

4.0

16.90

33651

185569

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

19289

77560

2.35

307.65

5.6

5.9

umol/l

10.3

11.8

57.01

18258

73048

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

19116

76620

2.34

307.65

6.6

6.3

mmol/l

1.2

22.40

16615

63893

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

5429

20573

1.87

307.65

2.7

2.5

22.8

23.5

3.00

4693

17623

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

34734

188765

4.40

307.65

17.2

10.1

mg/l

19.1

24.2

167.22

28900

140192

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

9506

39944

1.77

307.65

2.9

2.8

ng/l

1113.0

1349.8

5.73

7895

34024

(3005322) IgE [Units/volume] in Serum or Plasma

3376

9944

2.37

307.65

1.4

1.3

u/ml

185.6

309.3

8.80

3143

9191

(3008898) HLA-B27 [Presence]

3535

4175

6.09

307.65

1.1

1.0

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

31691

177712

2.24

307.65

14.6

10.1

ml/min/173m2

85.9

84.3

30.17

26846

141467

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1467

3052

3.27

307.65

1.4

ug/g

287.6

274.4

1.33

820

1787

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

24171

127318

1.74

307.65

3.4

2.6

u/l

45.4

44.0

1.69

22778

119555

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4888

15360

2.27

307.65

2.7

2.6

umol/l

6.7

9.6

15.04

4167

13321

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

13226

54617

1.94

307.65

3.6

2.9

ng/l

35.8

67.7

3.55

7946

35062

(3001604) Monocytes [#/volume] in Blood

21976

83259

2.83

307.65

7.0

5.5

e9/l

0.6

30.55

19409

71540

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1677

2725

4.22

307.65

1.3

1.2

u/ml

19.7

15.8

0.13

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

17193

80544

1.77

307.65

4.0

3.7

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

16229

66761

2.08

307.65

4.8

4.5

g/l

36.3

35.8

20.87

15133

61795

(3013826) Glucose [Moles/volume] in Serum or Plasma

20890

95490

2.03

307.65

4.9

4.3

mmol/l

6.5

6.7

42.31

19611

87199

(40758558) Short blood count panel - Blood

10885

40177

2.12

307.65

7.0

6.8

—

(3035941) MCH [Entitic mass]

36280

224311

4.15

307.65

24.7

15.2

30.3

30.2

2.43

36027

220618

(40768804) Tissue Pathology biopsy report

14851

70461

1.66

307.65

2.1

2.0

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

17225

67756

2.27

307.65

2.5

2.1

nmol/l

75.9

76.2

0.59

15784

61330

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

28832

128128

3.19

307.65

8.2

6.5

u/l

75.2

77.5

14.63

27525

119742

(3018010) Neutrophils/100 leukocytes in Blood

20655

81713

2.52

307.65

7.1

5.4

56.4

57.0

11.90

19508

76645

(3021788) Differential panel - Synovial fluid

1494

2264

4.51

307.65

1.6

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

3800

11008

2.43

307.65

2.6

g/l

10.4

10.8

6.19

3484

10085

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

15501

63978

2.04

307.65

2.1

1.8

pmol/l

97.7

96.3

2.97

8140

33390

(3002385) Erythrocyte distribution width [Ratio]

28521

164201

1.65

307.65

20.1

12.9

13.6

3.43

28190

160043

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

28204

140663

2.36

307.65

4.6

3.6

pmol/l

14.6

14.7

6.78

26112

127637

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

31950

182813

2.13

307.65

4.7

3.9

mmol/l

5.9

0.38

29770

167770

(3030467) Casts [#/volume] in Urine by Automated count

10957

40312

2.13

307.65

3.5

2.8

e6/l

0.3

0.5

15.55

8327

28995

(3026493) Urate [Moles/volume] in Serum or Plasma

12326

41341

2.46

307.65

2.5

umol/l

1624.0

4980.3

28.38

10775

36450

(3033658) Prothrombin time (PT) actual/Normal

10181

39472

1.97

307.65

4.2

3.5

93.4

90.4

25.52

9937

38488

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

30296

170709

1.95

307.65

5.8

5.0

mmol/mol

39.0

39.1

0.94

28490

158588

(3009261) Glucose [Presence] in Urine by Test strip

18761

83996

1.97

307.65

4.0

3.0

estimate

0.0

0.63

3431

14910

(40761511) CBC panel - Blood by Automated count

34804

204850

3.00

307.65

14.9

9.9

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4344

14908

2.05

307.65

1.8

1.6

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

4217

11306

2.66

307.65

2.6

2.1

u/l

40.4

41.6

0.08

3565

9556

(3021601) Nitrite [Presence] in Urine by Test strip

18583

83093

1.96

307.65

5.3

4.0

estimate

0.0

1.60

3524

15417

(3035350) Ketones [Presence] in Urine by Test strip

18605

82649

1.98

307.65

4.0

2.9

estimate

0.0

0.52

3392

15058

(3015377) Calcium [Moles/volume] in Serum or Plasma

12620

52459

1.90

307.65

2.9

3.4

mmol/l

2.4

2.02

11013

46011

(3024731) MCV [Entitic volume]

36279

224349

4.14

307.65

24.7

15.2

90.8

90.5

33.34

36025

220634

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1590

2715

4.01

307.65

1.3

1.2

u/ml

42.9

46.9

0.31

162

254

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

2521

3998

4.41

307.65

1.8

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

8992

35040

1.92

307.65

1.7

1.5

—

(3019198) Lymphocytes [#/volume] in Blood

22374

86686

2.78

307.65

7.1

5.5

e9/l

2.0

1.9

1.51

20089

75817

(3006504) Eosinophils/100 leukocytes in Blood

20417

79326

2.56

307.65

7.2

5.6

2.8

2.9

0.82

19267

73996

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2420

6255

2.67

307.65

2.2

2.0

u/l

39.5

39.8

0.23

2176

5539

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

6605

22833

2.11

307.65

3.1

2.6

e6/l

3.2

2.5

4.57

3518

11849

(3019069) Monocytes/100 leukocytes in Blood

20478

79837

2.56

307.65

7.5

5.9

8.4

8.6

16.44

19390

74908

(3019309) Folate [Moles/volume] in Red Blood Cells

6721

26125

1.86

307.65

1.8

1.7

nmol/l

1109.7

1168.9

5.52

5193

19409

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1917

4694

2.80

307.65

1.6

iu/ml

6.4

6.0

0.02

415

946

(3001122) Ferritin [Mass/volume] in Serum or Plasma

17656

76949

1.99

307.65

3.2

2.6

ug/l

106.3

123.0

10.56

16506

71743

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

2019

3402

4.10

307.65

1.3

1.2

u/ml

8.1

10.6

0.74

300

545

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1903

3382

3.87

307.65

1.5

1.4

—

(3013707) Erythrocyte sedimentation rate by Westergren method

29515

125406

3.73

307.65

5.5

3.3

mm/h

11.1

11.3

1.22

28076

115448

(3007164) IgA [Mass/volume] in Serum or Plasma

9351

31571

2.28

307.65

1.5

1.4

g/l

2.3

2.4

6.84

5547

19759

(3022145) Colonoscopy Study observation

4849

16539

2.08

307.65

1.4

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

35243

205873

3.64

307.65

18.4

12.1

umol/l

74.5

76.3

20.02

35234

205747

(36660697) Celiac disease serology panel - Serum

4168

12802

2.30

307.65

1.2

1.1

—

(3007461) Platelets [#/volume] in Blood

36269

224043

4.15

307.65

24.9

15.3

e9/l

258.9

251.8

82.38

35748

216910

(3015171) Extractable nuclear Ab [Units/volume] in Serum

3489

4855

5.15

307.65

1.3

1.2

u/ml

0.7

1.0

0.76

329

349

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

10041

37944

2.03

307.65

2.5

2.1

mg/l

2.8

2.9

5.11

8649

32149

(3044640) Blood type and Crossmatch panel - Blood

11951

51043

1.81

307.65

2.4

2.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

13508

64745

1.60

307.65

4.2

3.0

—

(36304419) Bacteria [Presence] in Urine

10863

39610

2.15

307.65

3.4

2.7

—

(3013115) Eosinophils [#/volume] in Blood

22580

86689

2.85

307.65

7.2

5.8

e9/l

0.2

0.85

20262

75494

(3018418) pH of Serum or Plasma

11943

44067

2.17

307.65

4.0

3.9

7.4

2.39

1846

8738

(3006315) Basophils [#/volume] in Blood

22092

83569

2.85

307.65

7.0

5.5

e9/l

0.0

1.90

19487

71822

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1656

2774

4.09

307.65

1.3

1.2

u/ml

2.2

7.5

2.13

114

210

(3026361) Erythrocytes [#/volume] in Blood

36282

224381

4.14

307.65

24.8

15.3

e12/l

4.5

4.6

65.42

35683

216621

(3002030) Lymphocytes/100 leukocytes in Blood

20798

83118

2.49

307.65

7.3

5.6

29.1

28.4

17.82

19608

77590

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2290

4205

3.78

307.65

1.8

1.6

g/l

1.2

1.76

2179

4008

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

17799

68980

2.36

307.65

5.8

mmol/l

1.2

25.10

16370

62154

(3000475) Leukocytes [#/volume] in Synovial fluid

1947

2897

4.64

307.65

1.7

1.6

e6/l

11945.4

14753.8

1.31

1405

2111

(40768797) Stomach Pathology biopsy report

6145

17829

2.54

307.65

1.2

—

(3000850) Epithelial cells [#/volume] in Urine

8401

29307

2.16

307.65

2.8

2.4

e6/l

5.5

5.4

0.33

7406

25187

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3179

9113

2.43

307.65

1.7

1.6

—

(3022096) Basophils/100 leukocytes in Blood

19894

76622

2.55

307.65

7.2

5.7

0.7

7.93

18773

71504

(3000963) Hemoglobin [Mass/volume] in Blood

36282

224506

4.12

307.65

25.0

15.3

g/l

135.6

137.0

73.26

36034

220851

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

12890

54708

1.86

307.65

3.3

3.0

u/l

31.4

33.9

3.26

12248

51871

(3036481) Cortisol [Moles/volume] in Serum or Plasma

4525

12972

2.49

307.65

2.2

2.3

nmol/l

363.9

386.2

10.46

4146

12023

(3023368) Bacteria identified in Blood by Culture

9595

38974

1.85

307.65

4.6

3.9

—

(3023420) DNA double strand Ab [Units/volume] in Serum

953

1524

4.22

306.99

1.6

1.5

iu/ml

30.6

43.4

1.06

(4010399)

3316

10821

2.13

303.97

1.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

4675

17285

1.90

303.72

22.3

23.1

inr

1.3

1.4

3.37

653

2150

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

761

1010

5.07

303.42

1.2

1.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2259

6247

2.48

302.78

1.5

1.6

u/ml

13.6

15.8

0.27

205

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

758

1007

5.07

301.91

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

758

1009

5.06

301.27

1.2

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

32147

192241

1.80

300.56

4.5

3.9

mmol/l

4.7

0.54

30303

179465

(40759836) Histone Ab [Presence] in Serum by Immunoblot

747

1003

5.01

294.15

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

748

1007

5.00

293.71

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

747

1007

4.99

292.89

1.2

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

31914

190873

1.76

289.72

4.5

3.9

mmol/l

1.5

4.09

29945

177544

(3004588) Protein electrophoresis panel - Serum or Plasma

2827

8827

2.21

288.36

2.1

2.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

2953

9433

2.16

284.77

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3134

10306

2.11

280.70

3.8

4.0

ng/l

83.2

91.8

5.29

2787

8940

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

30942

183857

1.69

280.59

4.0

3.5

mmol/l

1.3

41.52

28862

170223

(3020630) Protein [Mass/volume] in Serum or Plasma

3281

11072

2.05

274.34

2.2

2.5

g/l

67.3

66.5

7.26

2988

10108

(3000494) Fungus identified in Specimen by Culture

4869

18802

1.82

274.18

1.5

1.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1850

4866

2.60

273.85

1.7

1.6

titre

329.1

307.3

0.11

203

(3025941) Bacteria identified in Stool by Culture

2715

8516

2.20

273.37

1.3

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1837

4876

2.57

266.92

1.8

1.7

—

(3045414) Leukocytes [Presence] in Urine

2211

6412

2.36

266.74

1.9

1.7

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

956

1714

3.76

265.27

1.3

1.2

u/ml

50.5

56.4

0.23

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2168

6247

2.38

265.25

1.1

u/ml

8.8

10.0

0.06

104

(3019225) pH of Specimen

4022

14797

1.90

262.63

4.1

3.9

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1143

2397

3.22

251.98

1.8

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1258

2827

3.01

247.78

1.4

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

5446

22361

1.72

246.62

1.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1570

4053

2.63

240.54

2.2

2.0

mg/l

10.7

10.8

0.11

1465

3795

(3018677) aPTT in Platelet poor plasma by Coagulation assay

5537

22982

1.70

240.51

2.1

29.7

29.8

0.39

5361

22343

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

506

563

6.02

240.12

1.4

1.5

u/l

5.2

6.6

2.62

419

480

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2976

10155

2.02

240.07

3.2

3.5

pmol/l

4.5

4.6

1.87

2620

9158

(3038026) Centromere Ab [Units/volume] in Serum

676

998

4.55

239.37

1.3

1.2

u/ml

72.5

52.6

0.47

(3003458) Phosphate [Moles/volume] in Serum or Plasma

4902

19692

1.75

239.18

5.8

6.0

mmol/l

1.0

0.17

4589

18397

(3013512) EKG study

9550

45326

1.53

238.86

3.8

3.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

3433

12472

1.91

231.14

6.7

7.8

mmol/l

1.3

1.4

3.16

3311

12000

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2176

6662

2.23

231.02

2.4

2.3

u/l

6114.8

6228.5

0.05

729

2985

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

657

976

4.52

230.95

1.3

1.2

u/ml

50.9

38.7

0.53

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

656

975

4.52

230.47

1.3

1.2

u/ml

53.5

63.1

0.26

(3024980) IgG subclass 4 [Mass/volume] in Serum

1000

2073

3.25

224.30

1.4

1.6

g/l

0.6

0.9

10.05

775

1546

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

627

929

4.53

221.06

1.3

1.2

u/ml

4.9

15.5

1.14

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

861

1633

3.55

220.61

1.6

51.2

58.3

4.14

527

1076

(3017732) Neutrophils [#/volume] in Blood

3186

11460

1.92

220.45

2.6

2.8

e9/l

4.0

4.1

1.21

2438

9051

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2420

7887

2.10

219.81

1.7

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

5462

23156

1.66

216.96

2.1

2.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

5962

25875

1.63

215.90

2.2

2.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1646

4591

2.44

215.10

2.0

2.2

g/l

3.0

3.1

0.71

1298

3581

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1711

4890

2.38

212.09

2.0

2.2

g/l

7.4

7.3

1.04

1332

3651

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1703

4875

2.38

210.32

2.0

2.2

g/l

3.8

3.9

0.68

1274

3479

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1706

4890

2.37

210.08

2.0

2.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

30848

186307

1.57

209.74

18.1

11.3

40.2

40.3

0.97

23813

142136

(3009508) Creatinine [Moles/volume] in Urine

10799

53725

1.47

209.19

3.4

3.2

mmol/l

7.7

8.2

1.15

9187

45584

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2509

8472

2.03

207.12

1.1

1.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1494

4067

2.49

205.30

1.2

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

3524

13418

1.82

203.64

4.6

4.0

0.9

0.42

924

3601

(3020961) Endomysium IgA Ab [Titer] in Serum

2322

7682

2.07

202.31

1.1

titre

189.4

216.6

0.21

275

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1476

4034

2.48

201.10

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

1490

4095

2.47

200.65

1.2

1.1

—

(3021440) Promyelocytes/100 leukocytes in Blood

3386

12792

1.83

200.50

4.7

4.1

0.1

0.15

863

3364

(3002179) Metamyelocytes/100 leukocytes in Blood

3259

12202

1.84

198.49

4.3

3.8

0.5

0.7

1.07

708

2669

(3025159) Blasts/100 leukocytes in Blood

3246

12148

1.84

197.94

4.7

4.1

0.0

0.2

3.28

766

2923

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

650

1087

4.01

197.59

1.1

u/ml

24.8

83.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1469

4044

2.46

197.09

1.4

iu/ml

21.8

12.4

1.08

106

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1595

4573

2.37

196.07

2.0

2.2

g/l

10.1

10.4

2.21

1347

3833

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1381

3714

2.52

194.43

2.0

2.1

g/l

0.0

0.36

1264

3383

(3052851) Hemolysis interference index of Serum or Plasma

1455

4028

2.45

192.86

3.0

3.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

3238

12212

1.83

192.39

1.2

iu/ml

140.8

153.8

0.80

1157

4648

(3000492) Spirometry study

4236

17283

1.70

192.34

1.5

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1499

4218

2.41

191.88

2.1

2.3

g/l

0.7

0.9

1.25

1317

3597

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1403

3838

2.48

190.65

2.0

2.1

g/l

38.3

37.7

2.68

1224

3263

(3010144) Erythrocytes [#/volume] in Synovial fluid

651

1152

3.79

183.64

1.4

e6/l

119131.1

81524.9

0.61

454

779

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1286

3441

2.53

182.81

2.0

2.1

g/l

0.0

0.09

1175

3123

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3078

11603

1.82

182.72

2.7

ng/l

166.4

202.9

4.38

2733

10616

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1270

3393

2.53

181.08

2.0

2.2

g/l

0.0

0.00

1169

3119

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1456

4155

2.37

180.61

1.2

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

9409

46673

1.45

179.21

1.7

1.6

mmol/l

1.4

1.3

12.16

8246

39492

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1478

4279

2.34

177.54

1.9

1.7

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1573

4763

2.24

170.33

2.2

2.4

ug/l

275.8

711.4

6.54

1443

4469

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2918

11055

1.81

169.90

2.3

2.1

ug/l

5.8

9.2

12.60

2474

9660

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1726

5436

2.16

169.88

1.6

1.7

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1091

2789

2.64

169.69

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1524

4586

2.25

167.42

1.4

1.3

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

4240

17941

1.64

165.93

7.4

mmol/l

104.5

104.6

1.00

4169

17560

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4145

17445

1.64

165.65

3.5

4.4

u/l

236.5

245.4

2.24

3889

16586

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

645

1221

3.54

165.59

1.5

35.5

31.5

1.52

381

791

(3041096) Erythrocytes [Presence] in Urine by Automated

9342

46900

1.43

163.91

3.5

2.7

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3952

16475

1.66

163.75

7.1

7.9

kpa

5.1

0.53

3786

15677

(3027801) Oxygen [Partial pressure] in Arterial blood

3949

16460

1.66

163.72

7.1

7.9

kpa

12.6

12.8

1.24

3783

15657

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

6437

30144

1.50

161.46

1.5

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1193

3281

2.45

160.00

1.2

1.3

mg/l

518.5

562.1

0.66

1125

3129

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

6896

32812

1.48

159.76

1.6

1.7

—

(3003396) Base excess in Arterial blood by calculation

3932

16481

1.65

159.24

7.1

7.8

mmol/l

0.8

0.9

0.80

3152

12852

(3000991) Gas panel - Venous blood

3144

12450

1.73

157.03

8.3

9.0

—

(3027945) Reticulocytes/100 erythrocytes in Blood

3954

16669

1.64

156.37

2.5

2.6

1.7

0.47

3505

14733

(46235355) HIV 1 and 2 tests - Meaningful Use set

8207

40596

1.43

154.55

1.9

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

6915

33120

1.47

154.24

1.6

pmol/l

69918715.1

31268343.3

3.43

5874

27565

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2238

8034

1.90

153.69

1.5

—

(4062490)

650

1321

3.30

150.13

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

3511

14497

1.67

150.12

1.4

1.5

—

(3003338) MCHC [Mass/volume]

28546

172746

1.41

150.02

21.5

13.1

g/l

332.5

333.1

26.79

28397

171272

(3036071) Salmonella sp Ab [Titer] in Serum

340

410

5.53

149.47

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1064

2865

2.50

149.04

1.2

1.3

mmol/l

3.7

3.8

1.33

991

2705

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

3413

14028

1.67

148.39

2.5

2.2

g/l

0.2

13.04

3162

13077

(3027135) IgG subclass 1 [Mass/volume] in Serum

649

1329

3.27

148.15

1.4

g/l

6.5

7.0

1.88

473

888

(3024139) IgG subclass 3 [Mass/volume] in Serum

648

1328

3.27

147.75

1.4

g/l

0.4

2.65

476

890

(3028192) IgG subclass 2 [Mass/volume] in Serum

648

1329

3.27

147.57

1.4

g/l

3.0

0.28

475

891

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

399

568

4.69

147.27

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

1351

4078

2.24

147.08

1.3

1.2

titre

933.0

1073.8

0.29

116

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2017

7094

1.93

146.99

2.5

2.3

—

(3014051) Protein [Presence] in Urine by Test strip

1101

3037

2.44

146.63

2.2

1.9

—

(3016502) Oxygen saturation in Arterial blood

3519

14627

1.65

146.47

7.5

8.3

96.1

95.7

3.36

3393

14035

(3012516) Albumin [Mass/volume] in Urine

9507

48667

1.39

145.85

3.4

3.3

mg/l

511.7

288.7

3.73

6050

30779

(3004716) Salmonella sp identified in Stool by Organism specific culture

2450

9215

1.81

145.17

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1174

3354

2.36

144.91

1.2

1.3

—

(3024263) Appearance of Synovial fluid

421

639

4.40

144.29

1.9

1.7

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1033

2789

2.49

143.86

1.3

1.2

titre

80.0

122.1

0.74

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

4663

20964

1.54

139.41

4.4

4.1

31.4

32.2

5.97

3460

14296

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1450

4605

2.13

139.31

1.1

u/ml

4.6

5.8

0.48

140

731

(3007566) Smooth muscle Ab [Titer] in Serum

1357

4198

2.18

139.17

1.3

1.2

titre

114.8

132.1

0.31

122

390

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3248

13545

1.64

132.77

7.9

8.8

g/l

122.2

121.8

0.38

3149

13002

(3020682) Albumin/Creatinine [Ratio] in Urine

9825

51231

1.37

131.98

4.1

4.0

mg/mmol

9.6

9.0

0.50

6125

32931

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1956

7070

1.88

131.00

4.2

mmol/l

24.2

24.0

1.03

1776

6421

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2999

12313

1.67

130.07

2.9

2.4

ml/min/173m2

70.1

67.9

1.90

1177

4605

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2422

9385

1.76

129.44

3.6

3.7

kpa

5.1

0.21

2252

8706

(3009343) pH of Capillary blood

2398

9274

1.76

129.00

3.6

3.7

7.4

0.11

278

1207

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1022

2903

2.37

127.64

1.3

1.5

e6/l

1238.0

1362.0

0.08

824

2302

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1019

2902

2.36

126.53

1.2

1.4

e6/l

20.3

40.0

1.52

791

2192

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

4325

19512

1.53

126.28

6.7

5.8

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

5176

24309

1.48

124.41

1.8

1.7

1.5

1.4

11.82

4581

21854

(3044290) Cell count panel - Cerebral spinal fluid

990

2809

2.37

123.92

1.2

1.4

—

(3022621) pH of Urine by Test strip

2495

9923

1.71

121.40

3.0

2.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

2234

8619

1.76

120.92

1.4

1.3

iu/l

26.4

0.02

1953

7380

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

987

2828

2.35

120.89

1.3

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

987

2829

2.35

120.79

1.3

1.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2308

9005

1.74

120.16

3.6

mmol/l

1.4

1.7

3.33

1698

6609

(40768443) Skin Pathology biopsy report

1917

7135

1.82

116.80

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

852

2320

2.46

116.46

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3313

14317

1.58

116.35

2.1

2.0

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2039

7813

1.77

112.75

8.7

10.4

mmol/l

24.3

24.2

0.11

1931

7338

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

435

828

3.51

110.84

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

433

822

3.52

110.75

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

804

2217

2.43

107.00

1.5

—

(3023520) Reticulocytes [#/volume] in Blood

2854

12172

1.60

105.43

2.5

2.7

e9/l

70.3

69.2

0.86

2074

9056

(3012544) pH of Venous blood

3158

13796

1.56

105.31

4.2

3.8

7.3

7.4

1.69

(3002032) Base excess in Venous blood by calculation

3045

13198

1.57

105.05

4.2

3.8

mmol/l

1.7

1.8

0.49

2535

10714

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1642

6017

1.84

104.91

3.8

3.9

mmol/l

24.7

24.8

0.17

1530

5588

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

661

1671

2.65

104.88

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

648

1632

2.66

103.57

1.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3047

13270

1.57

102.87

4.2

3.8

kpa

5.9

5.8

1.25

2959

12870

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

679

1761

2.58

102.48

1.2

1.1

iu/ml

1.8

2.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

377

686

3.66

102.43

1.1

nmol/l

2.1

8.7

1.86

153

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

880

2581

2.29

102.18

1.4

1.3

u/l

25.4

25.6

0.08

699

2174

(3005988) Vibrio sp identified in Specimen by Organism specific culture

639

1612

2.65

101.80

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

760

2090

2.44

101.72

1.6

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

639

1613

2.65

101.68

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

646

1642

2.63

101.43

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

638

1612

2.65

101.34

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1564

5706

1.85

101.26

1.5

1.4

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

694

1834

2.53

100.88

1.3

nmol/l

0.2

0.44

123

(3020779) Urea [Moles/volume] in Serum or Plasma

3071

13489

1.55

99.73

7.4

7.5

mmol/l

9.1

9.6

4.53

2931

12861

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2697

11509

1.59

99.14

1.9

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

693

1846

2.51

99.12

1.3

nmol/l

1.8

1.9

0.03

661

1787

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1980

7805

1.72

98.88

2.5

3.3

u/ml

35.7

49.1

2.70

1894

7562

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

478

1056

3.02

96.62

1.1

mg/l

241.5

277.4

2.26

425

915

(3022313) Gas panel - Capillary blood

1781

6868

1.75

96.02

3.8

—

(3036489) Thrombin time

1612

6051

1.80

95.15

2.0

2.1

21.2

21.5

1.00

1371

5293

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1612

6053

1.80

95.05

2.1

1.8

—

(3014007) Fractional oxyhemoglobin in Arterial blood

2210

9080

1.65

94.46

9.0

10.3

94.2

94.0

0.99

2205

9044

(3047007) Chlamydophila sp Ab [Presence] in Serum

809

2374

2.28

93.81

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

484

1099

2.94

93.40

1.2

1.1

mg/l

34.6

48.4

7.36

419

894

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

567

1411

2.69

92.73

1.1

au/ml

46.5

58.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1247

4347

1.93

92.57

1.8

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1996

8040

1.68

91.93

8.9

10.5

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2191

9065

1.64

91.03

9.0

10.2

0.7

0.57

2180

9016

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1706

6610

1.74

90.37

1.7

g/l

1.6

1.5

1.71

1473

5630

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

611

1603

2.55

90.14

1.3

nmol/l

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2191

9091

1.63

89.98

8.9

10.1

1.4

1.3

1.23

2177

9033

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

458

1032

2.96

89.57

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1563

5931

1.78

88.90

1.3

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

217

282

5.12

88.59

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

217

282

5.12

88.59

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

217

282

5.12

88.59

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

217

282

5.12

88.59

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

849

2607

2.18

88.40

1.1

au/ml

7.7

11.9

1.29

185

(3028707) Methadone [Presence] in Urine by Screen method

998

3283

2.04

87.12

2.8

2.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1470

5515

1.80

86.81

2.0

1.7

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

336

634

3.53

86.79

1.5

5.1

4.1

0.37

154

(3045424) Erythrocytes [Presence] in Urine

841

2601

2.17

86.04

1.4

—

(3002256) Pathology report gross observation

4452

21754

1.40

83.43

1.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1296

4736

1.84

83.28

2.5

180.4

187.8

2.13

1211

4522

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

491

1199

2.73

83.23

1.2

titre

116.5

198.4

2.07

208

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

488

1197

2.72

82.05

1.2

titre

205.6

176.0

0.10

(3019420) Tryptase [Mass/volume] in Serum or Plasma

367

764

3.20

81.77

1.6

1.5

ug/l

7.7

0.02

339

688

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

275

469

3.90

81.66

1.9

mg/l

9.3

9.5

0.21

227

363

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

610

1678

2.43

81.61

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

4318

21247

1.39

77.19

1.5

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

505

1304

2.59

76.95

1.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

2444

10794

1.53

76.61

3.4

3.1

kpa

4.8

4.7

0.61

2362

10425

(4027681)

379

838

3.01

76.59

1.2

1.3

—

(3037121) Protein [Mass/volume] in Urine

1376

5310

1.74

73.71

2.9

3.4

g/l

0.3

0.50

553

2562

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

259

457

3.77

73.54

1.3

1.2

g/l

0.3

0.00

211

359

(3013166) Neutrophils/100 leukocytes in Synovial fluid

226

362

4.15

72.76

1.4

45.9

55.8

2.80

185

316

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1539

6169

1.68

71.86

1.3

1.4

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

283

542

3.48

71.63

2.3

2.9

au/ml

161.2

151.8

0.09

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

4310

21458

1.37

71.31

1.8

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

252

446

3.76

71.28

1.4

1.1

u/l

248.8

396.2

0.92

240

411

(3019060) Gas panel - Arterial blood

2096

9086

1.56

71.27

4.6

5.0

—

(3016018) Differential panel - Cerebral spinal fluid

544

1513

2.40

71.13

1.2

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1162

4315

1.81

70.83

1.2

1.1

—

(3023410) Appearance of Cerebral spinal fluid

506

1365

2.47

70.59

1.4

1.6

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

335

729

3.06

69.56

1.1

u/l

1.1

0.12

156

340

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

242

425

3.79

69.19

1.3

1.2

112.0

111.7

0.06

212

372

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

297

604

3.27

68.72

3.0

3.4

mg/l

7.5

8.4

1.20

238

480

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2158

9507

1.53

68.18

6.7

7.8

mmol/l

24.8

24.7

1.21

2141

9429

(3047181) Lactate [Moles/volume] in Blood

1151

4324

1.79

67.52

5.3

6.0

mmol/l

1.3

0.87

1027

3758

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1098

4067

1.81

67.47

2.0

1.9

iu/l

4.0

21.1

0.72

393

1570

(3026389) Candida sp identified in Specimen by Organism specific culture

655

2022

2.16

67.35

1.4

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

759

2499

2.03

66.09

1.3

1.2

u/ml

3.7

3.9

0.26

333

1153

(3024928) Oxygen saturation in Venous blood

863

2977

1.94

65.96

3.4

3.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

902

3161

1.91

65.82

1.4

1.3

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

220

378

3.87

64.79

1.7

1.6

au/ml

126.0

0.00

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

585

1755

2.23

64.47

2.1

1.9

mg/l

21.9

28.4

2.07

159

465

(3021387) Prolactin [Units/volume] in Serum or Plasma

1702

7201

1.59

64.08

1.6

mu/l

286.3

314.6

2.44

1541

6496

(3035947) Staphylolysin Ab [Units/volume] in Serum

309

674

3.05

63.96

1.2

1.1

iu/ml

3.4

3.8

0.25

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

680

2183

2.08

63.33

1.3

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1320

5251

1.69

63.32

2.1

2.4

94.5

91.4

5.40

1235

4909

(3035637) Corticotropin [Mass/volume] in Plasma

622

1937

2.14

62.60

1.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

1438

5903

1.64

61.17

1.4

u/l

10.4

8.9

3.68

1199

4801

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

309

694

2.96

60.92

1.1

u/ml

9.2

11.5

0.38

126

(3049717) Cytology report of Urine Cyto stain

1297

5210

1.67

59.97

2.4

2.8

—

(3011288) Drugs identified in Urine by Screen method

1396

5720

1.64

59.80

3.1

2.6

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1507

6305

1.61

59.37

1.3

miu/ml

224.4

228.6

0.16

692

3034

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

760

2610

1.95

58.86

1.3

1.2

u/ml

3.4

3.5

0.03

249

964

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

952

3521

1.81

58.77

1.2

1.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1949

8725

1.51

56.90

6.9

7.2

mmol/l

24.6

24.5

0.24

1818

8042

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

507

1518

2.23

56.19

1.2

u/l

55.1

75.0

4.02

344

1004

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

893

3300

1.81

55.28

1.2

1.3

u/ml

272.4

251.5

1.10

551

2108

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

181

303

3.97

55.23

1.2

1.3

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

501

1514

2.21

54.33

1.3

nmol/l

19.7

26.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1083

4256

1.70

54.29

2.9

3.1

mg/l

32.7

45.1

3.58

900

3383

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

245

515

3.16

53.94

2.3

1.6

umol/l

120.0

154.7

0.70

128

234

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

307

743

2.75

53.09

2.5

3.3

nmol/l

94.0

131.5

1.38

299

726

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1192

4837

1.65

52.99

2.6

2.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1080

4272

1.69

52.86

2.9

3.1

mg/l

41.4

64.1

1.21

894

3401

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

372

1000

2.48

52.40

1.1

iu/ml

9.9

7.4

0.71

284

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

229

470

3.24

52.37

1.3

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1713

7594

1.52

52.29

2.9

2.5

e6/l

0.2

0.3

2.66

1650

7385

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1441

6158

1.57

51.86

3.3

2.8

1.4

1.2

4.31

1432

6129

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1214

4980

1.63

51.72

2.7

2.6

g/l

3.7

3.6

0.26

1150

4771

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

758

2727

1.86

51.11

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

673

2330

1.93

50.95

1.5

1.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

855

3207

1.78

50.41

5.0

5.7

iu/ml

613.4

762.9

0.30

112

477

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1042

4140

1.69

50.17

2.9

3.1

ratio

1.6

4.3

2.64

300

(4306422)

698

2468

1.89

49.64

1.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

537

1730

2.07

49.63

7.2

6.2

mg/l

11.4

11.2

0.39

487

1594

(1001926) Buprenorphine [Presence] in Urine by Screen method

1553

6821

1.53

49.46

2.3

1.9

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1405

6041

1.56

49.22

3.3

2.8

0.6

0.7

1.03

1342

5801

(3037756) Immunofixation for Serum or Plasma

763

2789

1.83

48.95

1.7

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

679

2391

1.90

48.90

2.0

2.3

umol/l

5.7

6.7

0.97

495

1769

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1150

4723

1.63

48.76

2.9

3.3

u/ml

0.3

0.08

634

2644

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

317

819

2.58

48.44

1.4

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

702

2509

1.87

48.32

1.1

—

(4268621)

531

1722

2.06

48.24

2.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

389

1111

2.33

48.14

1.4

1.2

u/ml

0.8

1.3

0.74

199

456

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

281

689

2.71

47.50

1.7

1.8

138.7

147.1

0.85

269

650

(3036670) Protein [Mass/volume] in Synovial fluid

186

356

3.47

47.31

1.3

1.2

g/l

38.9

40.3

0.45

191

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

425

1273

2.22

47.14

1.3

1.5

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

308

797

2.57

46.94

1.2

u/l

20.4

24.0

0.60

266

685

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

674

2404

1.87

46.70

1.1

121.9

115.5

5.88

614

2175

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1278

5442

1.57

46.67

2.1

2.0

ug/l

1.9

2.3

0.54

1114

4794

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

514

1670

2.05

46.49

1.2

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

313

823

2.53

46.20

1.2

u/l

81.6

94.3

1.34

275

717

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

703

2553

1.84

46.06

1.1

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1032

4191

1.65

45.73

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

989

3973

1.67

45.69

1.1

u/ml

1.2

1.9

1.83

430

1657

(3035320) C reactive protein [Mass/volume] in Body fluid

360

1019

2.35

45.48

2.7

2.0

—

(3051611) Lipemic interference index of Serum or Plasma

470

1491

2.10

45.26

3.5

3.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

361

1030

2.33

44.81

1.1

1.2

mmol/l

1.9

2.2

2.40

328

951

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3005

15139

1.34

44.81

3.3

4.3

ug/l

15.2

27.8

1.58

2312

12208

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

207

441

3.12

44.70

1.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

6.21

44.14

1.0

1.1

u/ml

3.0

4.8

—

(3029075) Extractable nuclear Ab panel - Serum

206

442

3.10

43.99

1.1

1.0

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

449

1417

2.11

43.83

2.7

3.4

58.1

58.0

0.04

312

938

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

878

3462

1.70

43.49

1.6

—

(3019230) Fractional oxyhemoglobin in Venous blood

665

2430

1.83

42.75

3.4

3.1

64.1

66.3

1.67

665

2416

(4024509)

420

1306

2.14

42.58

1.7

1.5

—

(1002224) Polysomnography panel

1728

8000

1.45

42.43

1.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

429

1351

2.11

42.13

2.0

2.5

nmol/l

19.3

20.1

0.91

397

1286

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

274

707

2.58

42.05

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

200

434

3.06

41.95

1.3

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

185

384

3.20

41.68

1.5

ug/l

8.7

9.0

0.39

185

384

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

362

1068

2.26

41.68

2.1

2.5

e6/l

502.3

532.3

0.53

315

880

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

898

3607

1.66

41.52

1.4

1.5

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

352

1028

2.28

41.49

2.1

2.5

e9/l

0.2

0.64

311

876

(3023419) Bacteria identified in Sputum by Culture

495

1658

1.99

41.27

2.8

2.5

—

(3016879) Cocaine [Presence] in Urine

1802

8466

1.43

40.88

2.2

1.8

—

(4094501)

1035

4330

1.60

40.72

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

888

3582

1.66

40.40

1.4

1.5

u/ml

14.7

22.1

0.60

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

859

3437

1.67

40.31

1.4

pmol/l

118.0

138.1

0.49

834

3354

(3020717) Zinc [Moles/volume] in Serum or Plasma

264

687

2.55

39.87

1.5

umol/l

22.8

26.7

1.18

251

651

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

177

368

3.19

39.80

1.3

—

(3016244) Insulin [Units/volume] in Serum or Plasma

348

1030

2.25

39.79

3.1

mu/l

28.8

26.8

0.40

325

955

(3003888) Timothy IgE Ab [Units/volume] in Serum

890

3609

1.65

39.69

1.1

u/ml

5.1

6.1

1.00

499

1918

(3011985) Renin [Units/volume] in Plasma

578

2072

1.86

39.50

1.7

1.6

mu/l

73.6

60.3

0.52

511

1860

(3009015) Lactate [Moles/volume] in Synovial fluid

101

5.65

39.09

1.3

1.1

mmol/l

4.8

6.1

1.35

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

269

716

2.50

38.83

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

399

1268

2.09

38.33

4.1

4.2

—

(3011412) CD3 cells [#/volume] in Blood

453

1510

2.00

38.31

2.2

2.3

e9/l

1.2

1.1

2.05

258

916

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

839

3382

1.66

38.29

1.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2517

12647

1.34

37.97

3.7

mmol/l

1.2

0.18

2231

10988

(3000764) Benzodiazepines [Presence] in Urine

1903

9144

1.40

37.97

2.2

1.8

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

456

1529

1.99

37.95

1.6

1.7

—

(3028300) Cannabinoids [Presence] in Urine

1917

9233

1.39

37.72

2.2

1.8

—

(40760888) Immunoglobulin light chains.free panel - Serum

795

3175

1.67

37.59

3.0

3.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

669

2548

1.75

37.53

1.1

u/ml

3.3

2.8

0.33

255

1361

(3004119) Hemoglobin [Mass/volume] in Venous blood

1766

8400

1.41

37.35

3.6

3.2

g/l

129.6

129.7

0.05

1723

8207

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

249

651

2.54

37.30

1.6

1.7

nmol/l

2.8

7.8

0.77

208

554

(3013005) Retinol [Moles/volume] in Serum or Plasma

225

561

2.66

36.98

1.8

1.9

umol/l

2.1

1.9

1.55

201

535

(3027008) Opiates [Presence] in Urine

1908

9213

1.39

36.97

2.2

1.8

—

(21494755) Public health laboratory ask at order entry panel

3042

25400

0.77

36.69

1.3

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

131

235

3.70

36.64

1.1

umol/24h

11.0

0.7

0.50

121

(21491868) Cryoglobulin [Mass/volume] in Serum

204

488

2.78

36.23

1.1

1.2

g/l

0.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

193

448

2.86

36.18

1.1

103.4

84.7

5.66

225

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

507

1794

1.88

36.10

1.1

95.4

96.3

0.29

468

1688

(3016650) Hepatitis A virus Ab [Presence] in Serum

712

2799

1.70

35.72

1.1

—

(3007916) DNA double strand Ab [Titer] in Serum

133

4.69

35.28

1.6

1.2

titre

122.8

231.3

—

(44813793)

364

1155

2.10

35.16

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

837

3447

1.62

35.15

1.1

u/ml

1.1

0.02

390

1496

(4034850)

1141

5048

1.51

35.09

10.7

8.2

—

(3044927) Protein electrophoresis panel - Urine

387

1259

2.05

35.02

1.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

198

475

2.77

35.00

1.1

1.2

119.5

100.5

6.89

178

435

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

369

1180

2.08

34.93

1.1

mg/l

291.7

287.4

0.46

330

1071

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

364

1158

2.09

34.93

2.1

2.6

e6/l

836.0

656.9

3.50

156

443

(3010726) Horse dander IgE Ab [Units/volume] in Serum

825

3401

1.62

34.51

1.1

u/ml

2.0

2.5

0.45

231

865

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

529

1928

1.83

34.38

1.4

pmol/l

308.1

287.4

0.66

409

1498

(3002619) Bacteria identified in Specimen by Culture

129

240

3.57

34.32

1.3

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

815

3355

1.62

34.29

1.4

1.5

u/ml

118.3

111.6

0.52

171

734

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

418

1410

1.97

34.26

1.6

1.7

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

207

516

2.66

34.09

1.1

ng/l

290.0

714.9

0.69

140

(40761536) Microorganisms panel - Urine sediment

2821

14627

1.30

33.93

4.4

3.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

576

2164

1.77

33.90

1.1

g/l

1.5

0.42

510

1963

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

643

2495

1.72

33.84

1.6

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

196

477

2.73

33.77

1.1

98.2

86.6

4.63

243

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

740

2987

1.65

33.64

1.5

nmol/l

0.3

0.4

2.65

560

2407

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

276

797

2.30

33.50

1.2

1.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

634

2461

1.72

33.33

2.6

3.0

u/ml

1115.1

2536.9

1.24

151

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

204

513

2.64

33.05

1.7

1.8

143.7

177.6

5.27

191

486

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

268

769

2.32

33.01

1.3

1.2

titre

70.0

100.9

0.45

(3027944) Amphetamines [Presence] in Urine

1856

9093

1.37

32.87

2.1

1.8

—

(3005011) Chlamydia sp Ab [Titer] in Serum

115

204

3.74

32.71

1.5

1.7

—

(3010838) Calcium [Moles/time] in 24 hour Urine

243

670

2.41

32.67

1.5

1.6

mmol/24h

4.0

5.6

1.63

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

242

668

2.41

32.46

1.2

1.3

59.7

62.8

0.15

(3000330) Specific gravity of Urine by Test strip

1538

7323

1.41

32.30

3.2

2.9

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

270

785

2.29

32.29

1.3

1.4

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

273

799

2.27

32.16

1.3

1.2

titre

502.0

447.5

0.06

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

421

1457

1.92

32.09

2.7

3.1

nmol/l

17.9

5.6

0.45

401

1412

(3020891) Body temperature

1191

5415

1.47

32.07

4.9

—

(3039000) Anion gap in Blood

777

3224

1.61

31.69

6.2

6.9

mmol/l

11.4

11.2

0.42

710

2870

(3018572) Chloride [Moles/volume] in Blood

777

3225

1.61

31.65

6.2

6.9

mmol/l

105.2

0.20

710

2871

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

159

357

2.96

31.64

1.4

1.2

40.3

38.2

0.22

105

253

(3008757) Leukocyte morphology finding [Identifier] in Blood

461

1656

1.85

31.41

3.3

3.6

—

(3004809) Band form neutrophils/100 leukocytes in Blood

621

2437

1.70

31.41

2.9

3.3

1.1

1.5

2.97

489

1935

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1079

4837

1.49

31.17

2.9

3.6

u/ml

476.3

985.0

1.34

912

4184

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2835

14867

1.28

31.16

2.4

2.1

nmol/l

12.3

12.8

2.41

2512

13391

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

460

1656

1.85

31.14

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

311

974

2.12

31.13

1.4

1.2

umol/l

4.8

5.5

2.30

276

909

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1292

6005

1.44

31.02

2.0

1.7

nmol/l

39.5

41.3

1.72

1261

5875

(3015235) Bicarbonate [Moles/volume] in Capillary blood

845

3599

1.57

30.88

3.0

3.1

mmol/l

24.4

24.6

0.90

739

3206

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

354

1172

2.01

30.62

1.4

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

927

4043

1.53

30.49

2.1

1.8

pmol/l

191.9

201.6

1.98

863

3884

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

255

746

2.27

30.11

1.2

1.1

u/ml

12.2

7.4

0.21

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

294

913

2.14

30.08

1.4

1.6

u/ml

23.1

23.9

0.07

201

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3046

16230

1.26

29.34

3.4

3.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

393

1372

1.91

29.25

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

132

278

3.15

29.23

1.8

1.5

ug/l

0.4

0.09

180

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

220

611

2.39

29.19

1.3

1.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

371

1271

1.94

29.18

1.5

1.3

promille

1.4

0.36

289

1016

(3023183) Ammonium ion [Moles/volume] in Plasma

737

3081

1.60

29.18

3.1

2.6

umol/l

34.3

34.1

0.09

636

2625

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

309

991

2.07

29.14

1.1

1.2

ratio

1.1

0.09

100

378

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

771

3260

1.58

29.10

1.6

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

220

612

2.39

29.09

1.3

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

669

2733

1.63

29.08

1.2

—

(44790047)

443

1615

1.83

28.86

1.6

1.5

—

(44790049)

443

1615

1.83

28.86

1.6

1.5

—

(44790048)

443

1616

1.82

28.80

1.6

1.5

—

(44806118)

443

1616

1.82

28.80

1.6

1.5

—

(3018405) Lactate [Moles/volume] in Arterial blood

1036

4691

1.48

28.50

4.1

4.4

mmol/l

1.3

1.4

1.97

1028

4599

(3051651) Icteric interference index of Serum or Plasma

270

832

2.16

28.20

3.8

4.0

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

829

3590

1.54

28.19

2.1

g/l

131.0

131.3

0.15

556

2619

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

629

2564

1.63

27.60

1.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

400

1438

1.85

27.27

1.1

titre

—

60.0

—

(1761868) Lipid panel - Serum or Plasma

10490

76334

0.87

27.06

2.5

2.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

347

1195

1.93

26.93

1.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

343

1182

1.93

26.58

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

343

1182

1.93

26.58

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

343

1182

1.93

26.58

1.6

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

288

932

2.05

26.57

1.9

2.3

101.6

96.8

1.51

263

880

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

756

3255

1.55

26.41

1.5

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

127

4.18

26.35

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

284

918

2.06

26.29

1.7

1.5

u/l

5.4

6.3

0.40

146

438

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

144

341

2.80

26.21

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

141

330

2.84

26.21

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

106

210

3.35

25.86

1.7

1.6

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

114

239

3.16

25.50

1.2

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

4.84

25.40

1.0

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

192

536

2.38

25.27

1.1

1.0

u/ml

12.9

13.7

0.06

(3043409) Potassium [Moles/volume] in Arterial blood

892

4017

1.48

25.25

4.4

4.7

mmol/l

3.8

3.9

5.89

848

3765

(3000093) Morphology [Interpretation] in Blood Narrative

405

1498

1.80

25.25

1.2

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

324

1118

1.93

25.05

2.1

1.9

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

317

1088

1.94

24.89

1.2

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1201

5733

1.40

24.87

5.1

0.9

4.18

1125

5332

(3045683) HLA typing for celiac disease panel - Blood or Tissue

308

1047

1.96

24.86

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

188

525

2.38

24.74

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

104

211

3.27

24.50

1.2

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

195

557

2.32

24.42

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

608

2545

1.59

24.03

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

140

343

2.71

23.99

1.2

1.3

nmol/l

129.6

125.9

0.09

103

253

(3006245) CD3-CD19+ cells/100 cells in Blood

202

593

2.26

23.79

2.2

2.0

9.1

11.7

2.45

186

545

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

200

588

2.26

23.48

2.0

1.9

27.2

29.4

1.41

186

555

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1214

5871

1.38

23.28

5.1

5.0

1.8

1.7

2.20

1137

5459

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

579

2415

1.60

23.24

1.3

1.2

—

(4198724)

248

801

2.06

23.08

1.9

2.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

150

389

2.56

23.06

1.0

1.1

—

(1175426) CD3 cells/100 lymphocytes in Blood

338

1217

1.85

23.02

2.0

1.9

74.9

71.7

3.97

320

1171

(3023430) Cat dander IgE Ab [Units/volume] in Serum

632

2699

1.56

22.95

1.1

u/ml

5.9

5.2

0.28

294

1158

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

110

4.16

22.67

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

154

410

2.49

22.47

1.3

1.4

—

(3015183) Erythrocyte sedimentation rate

268

900

1.98

22.45

1.2

1.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

133

329

2.68

22.42

1.1

mg/g

6.9

6.8

0.05

124

313

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

151

3.60

22.31

1.7

1.6

mg/l

1.8

1.7

0.24

122

(3014133) Dog dander IgE Ab [Units/volume] in Serum

670

2922

1.53

22.16

1.1

u/ml

5.5

4.1

0.76

288

1173

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

330

1201

1.83

21.76

2.0

1.9

14.2

13.9

0.15

180

538

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

180

523

2.28

21.76

1.4

pmol/l

13.8

14.8

1.53

146

452

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

193

578

2.22

21.74

1.9

1.8

umol/l

29.7

29.0

0.47

182

558

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

302

1069

1.88

21.72

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

263

889

1.97

21.66

1.3

1.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

783

3545

1.47

21.64

3.2

3.6

kpa

8.7

8.5

2.39

730

3317

(3003721) Smooth muscle Ab [Units/volume] in Serum

4.86

21.63

1.3

1.1

u/ml

1.4

2.7

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

103

4.18

21.53

1.1

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

302

1075

1.87

21.36

1.1

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

302

1078

1.86

21.18

1.7

1.8

mg/l

3.4

3.9

0.95

286

1026

(3006922) Hepatitis E virus Ab [Presence] in Serum

317

1150

1.83

21.14

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

135

348

2.57

21.06

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

212

671

2.10

20.86

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

165

471

2.32

20.79

2.2

3.3

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.19

20.62

1.5

1.6

mg/l

1.5

1.9

0.23

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

170

495

2.28

20.48

2.5

2.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

550

2340

1.56

20.36

1.0

u/ml

0.2

0.4

1.68

156

496

(21494890) Protein electrophoresis panel - 24 hour Urine

362

1383

1.74

20.35

1.8

2.0

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

12.74

20.16

1.6

1.5

nmol/l

326.8

141.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

630

2771

1.51

20.08

3.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

801

3697

1.44

20.08

1.8

1.6

—

(3003181) Sodium [Moles/volume] in Urine

542

2309

1.56

19.96

1.5

1.4

mmol/l

64.2

64.8

0.12

427

1804

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

484

2008

1.60

19.94

1.4

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

8.56

19.84

1.0

—

(3025577) Chromium [Mass/volume] in Blood

249

854

1.94

19.72

2.2

2.0

ug/l

1.9

2.2

0.81

199

720

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1492

7633

1.31

19.70

1.7

1.6

mg/l

4.0

3.2

1.88

1114

5032

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

4.14

19.67

1.5

mg/l

2.0

0.02

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

4.14

19.67

1.5

mg/l

2.1

2.5

0.19

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

4.14

19.67

1.5

mg/l

1.6

1.4

0.07

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

4.14

19.67

1.5

mg/l

1.8

2.1

0.13

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

4.14

19.67

1.5

mg/l

1.5

3.4

1.28

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

4.14

19.67

1.5

mg/l

3.5

2.1

0.59

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

4.14

19.67

1.5

mg/l

5.3

3.9

0.47

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

4.14

19.67

1.5

mg/l

3.4

2.5

0.40

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

4.14

19.67

1.5

mg/l

1.2

0.5

1.02

(3026470) Cobalt [Mass/volume] in Blood

252

870

1.92

19.59

2.1

2.0

ug/l

3.2

3.4

0.25

221

778

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

345

1319

1.74

19.37

1.2

1.3

—

62.7

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

344

1316

1.74

19.28

1.3

—

(3036603) Volume of Urine

294

1074

1.82

19.23

1.5

1.6

1929.1

1940.1

0.03

237

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

119

3.73

19.21

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

152

434

2.32

19.18

2.0

1.9

e6/l

133.9

921.5

0.75

218

(3032057) Clostridioides difficile [Presence] in Stool

100

232

2.86

19.02

1.9

—

(3042951) Complement C1q Ab [Units/volume] in Serum

5.30

18.97

1.1

1.2

u/ml

9.1

18.5

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

4.31

18.60

1.1

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

129

347

2.47

18.53

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

472

1984

1.58

18.46

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

571

2508

1.51

18.37

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

8066

58579

0.89

18.36

4.6

4.5

ug/l

2.3

3.1

2.85

7333

52918

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

215

2.90

18.35

1.1

u/ml

0.0

0.3

1.27

136

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

510

2186

1.55

18.33

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

127

342

2.46

18.21

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

201

658

2.03

18.18

2.2

2.4

ug/l

22.7

280.2

1.12

194

618

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

4.21

18.09

1.0

u/ml

0.2

1.3

1.95

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

317

1208

1.74

18.05

1.2

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

260

933

1.85

18.03

2.5

2.7

43.0

37.9

2.32

310

(3011648) Oxygen content in Venous blood

303

1141

1.76

17.97

2.3

2.7

11.3

11.5

0.29

303

1141

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

221

752

1.95

17.96

1.4

1.6

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

122

3.59

17.94

1.1

umol/24h

7.1

1.6

0.49

122

(3019174) dRVVT (LA screen)

135

3.44

17.92

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

128

350

2.43

17.79

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

170

3.12

17.67

1.8

1.5

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

307

1170

1.74

17.49

1.4

1.3

umol/l

11.9

12.0

0.17

290

1101

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

198

2.91

17.16

1.2

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

120

324

2.46

17.14

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

214

735

1.93

16.97

1.6

1.9

—

(40768441) Liver Pathology biopsy report

291

1102

1.75

16.97

1.3

1.4

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

107

275

2.58

16.90

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

445

1886

1.57

16.85

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

116

311

2.47

16.83

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

230

813

1.88

16.75

1.9

1.5

nmol/l

1.4

1.3

0.62

178

654

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

447

1902

1.56

16.65

1.4

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

117

317

2.45

16.61

1.2

93.7

85.6

0.73

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

389

1605

1.61

16.49

3.9

5.2

u/ml

122.9

89.0

0.32

122

522

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

5.80

16.47

1.0

1.1

g/l

0.2

0.84

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

277

1044

1.76

16.43

1.5

1.8

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

4.52

16.41

1.2

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

317

1243

1.69

16.36

1.9

2.0

g/24h

1.5

1.0

0.39

(4211845)

229

815

1.87

16.35

3.1

2.5

—

(4015189)

123

344

2.37

16.33

2.2

2.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

6361

46585

0.88

16.30

3.9

22.1

21.7

0.97

2571

21675

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

116

316

2.43

16.29

1.1

1.2

76.7

77.4

0.04

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

211

733

1.91

16.21

1.6

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

211

733

1.91

16.21

1.6

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

211

733

1.91

16.21

1.6

1.9

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

119

329

2.40

16.20

1.1

1.4

110.9

105.3

1.09

114

307

(3008295) Osmolality of Serum or Plasma

362

1474

1.63

16.19

1.5

1.6

mosm/kgh2o

281.2

280.4

0.30

271

1179

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

168

539

2.07

16.10

1.1

—

(3042517) Benzodiazepines panel - Urine

156

3.10

16.02

2.7

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

167

537

2.06

15.91

1.2

1.1

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

10.41

15.91

1.7

1.6

nmol/l

324.2

130.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

868

4235

1.37

15.88

1.3

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

487

2135

1.52

15.88

2.4

3.0

u/ml

271.7

683.1

0.59

469

2010

(21494815) CD4 cells/100 lymphocytes in Specimen

365

1499

1.62

15.80

2.0

2.1

43.6

40.9

0.54

177

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

520

2315

1.49

15.77

1.7

2.0

titre

1221.1

3341.8

1.91

119

(3028433) Virus identified in Specimen by Culture

149

460

2.15

15.76

1.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

126

363

2.30

15.69

1.4

1.3

umol/l

17.2

17.0

0.17

111

324

(3042631) Mycobacterium sp identified in Specimen

458

1991

1.53

15.54

2.4

2.6

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

116

324

2.37

15.47

1.8

2.1

umol/l

15.1

17.1

1.12

116

324

(3024869) Neuronal Ab [Presence] in Serum

245

2.60

15.41

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

189

2.84

15.35

1.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

601

2770

1.44

15.30

2.0

2.3

titre

3.4

8.5

1.17

(3003694) ABO and Rh group [Type] in Blood

9380

57384

1.11

15.23

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

259

980

1.75

15.21

1.3

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

4110

23902

1.16

15.16

1.7

—

(1616796) Gas panel - Central venous blood

699

3317

1.40

15.15

3.6

3.5

—

(3041672) Baker's yeast Ab [Presence] in Serum

4.53

15.01

1.1

1.0

—

(3021901) Oxygen saturation in Capillary blood

573

2629

1.45

14.95

2.8

2.9

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

135

3.19

14.95

1.0

—

(3011897) Casein IgE Ab [Units/volume] in Serum

105

285

2.44

14.91

1.1

1.3

u/ml

2.4

7.1

0.78

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

278

1080

1.71

14.89

1.5

1.4

—

(3006462) Nitrate [Presence] in Urine

208

741

1.86

14.86

3.2

2.5

—

(3018001) Oat IgE Ab [Units/volume] in Serum

106

3.50

14.79

1.0

u/ml

0.2

0.01

(3010375) cycloSPORINE [Mass/volume] in Blood

195

682

1.90

14.74

29.1

27.1

ug/l

103.6

122.4

3.47

164

563

(40757494) Bilirubin.total [Moles/volume] in Blood

191

666

1.90

14.57

2.1

umol/l

22.4

37.5

0.59

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

4.28

14.42

1.3

1.4

mg/l

1.5

0.10

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

201

716

1.86

14.38

1.1

102.0

95.6

2.20

161

565

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

3.83

14.36

1.1

u/ml

24.0

57.3

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

3.83

14.36

1.1

u/ml

23.9

32.8

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

117

340

2.28

14.33

1.0

1.1

u/ml

2.6

2.9

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

205

2.68

14.22

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

150

3.00

14.22

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

202

724

1.85

14.19

1.2

1.3

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

170

575

1.96

14.18

2.2

2.7

ug/l

1.0

1.1

0.11

153

536

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

225

835

1.79

14.14

1.2

—

(3030313) Adrenal Ab [Titer] in Serum

147

3.02

14.14

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

173

591

1.94

14.03

1.7

1.6

—

(3034426) Prothrombin time (PT)

169

574

1.95

13.94

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1203

6272

1.28

13.82

1.5

1.4

—

(4035726)

2670

15124

1.18

13.74

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

385

1658

1.54

13.70

1.6

1.5

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

136

3.07

13.66

1.0

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

234

2.52

13.54

1.1

1.4

titre

34.2

227.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

111

324

2.27

13.49

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

654

3136

1.39

13.39

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

216

2.58

13.36

1.0

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

167

2.82

13.33

1.0

u/ml

0.2

0.3

0.56

102

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

938

4756

1.31

13.33

3.4

3.6

mg/l

1.5

1.4

2.03

873

4397

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

198

720

1.82

13.33

2.1

ug/min

102.7

97.6

0.04

175

(3001964) Herpes simplex virus Ag [Presence] in Specimen

141

457

2.05

13.26

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

652

3136

1.38

13.12

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

167

579

1.91

13.02

2.7

2.9

—

(3043410) Blood group antigens tested for on Red Blood Cells

121

373

2.15

12.94

1.6

1.7

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

111

331

2.22

12.86

1.1

u/ml

0.7

16.2

3.89

238

(3012494) Peanut IgE Ab [Units/volume] in Serum

150

508

1.96

12.53

1.1

u/ml

2.9

18.1

1.22

299

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

171

607

1.87

12.45

1.7

2.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

257

1031

1.65

12.33

1.7

1.8

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

315

1330

1.57

12.29

2.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

167

592

1.87

12.22

1.7

2.0

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

172

2.70

12.18

1.1

u/ml

0.1

7.3

1.75

134

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

210

800

1.74

12.17

1.1

miu/ml

1628.3

1413.7

1.72

210

800

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

167

593

1.87

12.16

1.7

2.0

—

(3017704) Immunofixation for Urine

197

738

1.77

12.09

1.7

1.6

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

173

2.68

12.05

1.0

1.1

u/ml

0.2

4.9

2.34

135

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

258

1043

1.64

12.03

1.7

1.6

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

208

793

1.74

12.02

1.2

1.1

u/l

76.2

85.2

1.20

169

631

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

167

596

1.86

11.98

2.4

2.3

—

(3000034) Microalbumin [Mass/volume] in Urine

337

1454

1.54

11.97

2.8

3.0

mg/l

73.0

56.5

0.37

241

1043

(37021550) Renin [Units/volume] in Plasma --upright

100

295

2.25

11.92

1.3

mu/l

97.6

74.2

0.43

226

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

207

791

1.74

11.88

1.2

1.1

u/l

18.1

25.8

1.73

162

610

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

129

423

2.02

11.82

1.1

1.3

16.6

23.0

0.37

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

175

2.65

11.81

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

122

392

2.06

11.80

1.2

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.43

11.61

1.2

1.3

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

3.87

11.59

1.1

u/l

45.4

72.6

0.67

(3006442) Creatine [Moles/volume] in Serum or Plasma

272

1128

1.60

11.48

1.7

1.4

umol/l

64.0

74.2

1.46

112

(3025130) Human papilloma virus identified in Specimen

551

2641

1.39

11.39

1.7

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

167

2.66

11.38

1.0

1.1

u/ml

0.1

0.6

1.37

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

416

1898

1.46

11.32

1.1

1.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

255

1046

1.62

11.26

1.2

1.1

—

(4146454)

387

1743

1.47

11.25

2.6

2.8

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

145

505

1.90

11.23

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

111

351

2.10

11.21

1.1

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

570

2756

1.37

11.19

2.9

3.5

u/ml

1147.9

707.9

0.17

520

2502

(3042111) Morphology [Interpretation] in Bone marrow Narrative

503

2387

1.40

11.05

1.5

1.7

—

(40768800) Prostate Pathology biopsy report

396

3745

0.70

11.02

1.2

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

172

637

1.79

11.01

1.6

1.4

mu/l

512.5

728.4

0.92

164

604

(3018133) Calcium [Moles/volume] in Urine

272

2.24

10.96

1.9

2.2

mmol/l

2.8

0.07

246

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

180

677

1.76

10.95

2.0

—

(3003129) Base excess in Capillary blood by calculation

112

359

2.07

10.94

1.5

1.6

mmol/l

0.8

0.3

0.62

105

339

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

129

1575

0.54

10.90

14.9

18.9

nmol/l

1345.2

2976.9

0.81

116

1516

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

120

1492

0.53

10.79

12.1

13.3

nmol/l

757.4

1850.0

0.83

114

1451

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

174

652

1.77

10.73

1.5

1.4

74.3

72.3

1.40

166

619

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2921

21929

0.87

10.64

1.7

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

197

2.46

10.63

1.4

nmol/l

510007.4

276653.3

0.24

167

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

311

1356

1.52

10.60

1.4

1.3

nmol/l

1.5

1.4

1.01

280

1212

(3045716) Anion gap in Serum or Plasma

167

621

1.78

10.57

2.6

2.5

mmol/l

8.2

9.3

3.86

126

461

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

182

2.51

10.53

1.0

1.1

u/ml

0.5

6.5

1.10

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

115

2.94

10.39

1.3

1.2

nmol/l

16.8

16.1

0.08

(3020491) Glucose [Moles/volume] in Blood

293

1267

1.53

10.38

1.7

mmol/l

6.6

0.05

221

906

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1125

6034

1.24

10.26

3.9

3.6

51.6

48.1

4.76

1109

5964

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.14

10.21

1.8

1.6

umol/l

51.4

45.1

0.45

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

177

2.51

10.21

1.0

1.1

u/ml

0.1

1.2

1.80

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

101

320

2.09

10.20

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

101

320

2.09

10.20

1.1

—

(3014271) Vancomycin [Susceptibility]

173

660

1.74

10.07

3.1

2.8

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

100

319

2.08

9.93

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

204

2.37

9.91

13.2

9.9

mmol/l

5.5

5.6

0.07

204

(3027273) Bicarbonate [Moles/volume] in Venous blood

1224

6656

1.22

9.82

3.8

3.2

mmol/l

25.2

0.08

1177

6429

(3026250) Tacrolimus [Mass/volume] in Blood

183

716

1.70

9.76

34.2

36.1

ug/l

7.2

7.4

0.63

163

648

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

313

2.08

9.72

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

516

2516

1.36

9.69

4.7

5.2

umol/l

354.4

377.5

2.96

448

2182

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

298

1317

1.50

9.59

1.7

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

294

2.10

9.48

1.3

1.6

nmol/l

0.2

0.16

222

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

252

2.18

9.35

1.3

1.4

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.80

9.29

1.2

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

111

379

1.94

9.21

1.9

1.8

u/l

48.8

39.0

0.17

345

(40767503) Oxygen content in Capillary blood by calculation

637

3230

1.31

9.21

2.7

2.4

16.8

16.7

0.23

354

1650

(3022806) Fractional oxyhemoglobin in Capillary blood

397

1873

1.41

9.12

2.0

1.7

90.4

89.8

1.22

391

1840

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

103

344

1.98

9.10

1.2

pmol/l

308.3

377.4

0.48

257

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

140

519

1.79

9.04

1.0

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

129

2.67

9.00

1.1

mg/l

56.2

43.0

0.65

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

272

1197

1.51

8.97

1.1

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

3.53

8.94

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

140

523

1.77

8.82

1.4

1.6

u/ml

1721.8

16879.2

0.91

(3036180) Methadone [Presence] in Urine

5.96

8.74

3.2

2.9

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

4.62

8.69

1.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

501

2477

1.34

8.66

1.2

1.3

u/l

29.8

33.7

0.29

449

2123

(44806071)

209

2.25

8.64

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1352

7544

1.19

8.36

2.0

1.8

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.89

8.35

1.1

1.4

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

214

2.20

8.20

2.5

2.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

199

2.23

8.02

1.2

—

(3047189) Immunofixation for 24 hour Urine

154

609

1.68

7.99

1.8

—

(3016038) Potassium [Moles/volume] in Urine

211

903

1.55

7.96

1.4

1.3

mmol/l

33.1

36.0

1.03

175

795

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

101

352

1.90

7.96

1.2

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

575

2937

1.30

7.95

1.1

iu/ml

49.9

953.4

1.11

133

670

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

217

2.17

7.95

1.1

—

(3027315) Oxygen [Partial pressure] in Blood

662

3449

1.28

7.86

4.1

3.7

kpa

8.9

8.7

1.63

646

3369

(40762814) Titanium [Mass/volume] in Blood

240

2.10

7.85

2.5

2.3

ug/l

3.8

4.0

0.13

(3022493) Free Hemoglobin [Mass/volume] in Plasma

168

684

1.63

7.81

4.4

6.2

mg/l

3716.8

2933.6

0.14

121

493

(3008116) Ketones [Moles/volume] in Urine by Test strip

273

2.01

7.72

1.5

1.4

—

(3010421) pH of Blood

748

3964

1.25

7.71

4.1

3.7

7.4

1.84

641

3354

(3012501) Base excess in Blood by calculation

657

3429

1.27

7.70

4.1

3.7

mmol/l

2.4

2.5

0.15

432

2303

(3052592) Norovirus Ag [Presence] in Stool

260

2.04

7.68

1.1

1.4

—

(3013290) Carbon dioxide [Partial pressure] in Blood

657

3430

1.27

7.68

4.1

3.7

kpa

5.0

0.72

641

3351

(3028271) Lactate [Moles/volume] in Capillary blood

470

2349

1.33

7.62

2.0

1.8

mmol/l

1.6

1.8

4.53

458

2284

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

110

2.65

7.57

1.1

1.0

iu/ml

31.5

14.7

0.59

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.79

7.55

1.1

u/l

6.4

12.7

1.35

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1963

14789

0.87

7.54

1.4

—

(3001729) Color of Synovial fluid

103

2.70

7.49

1.5

1.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

126

481

1.74

7.46

1.5

1.4

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

180

2.25

7.44

3.7

3.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

147

2.39

7.42

1.2

1.1

—

(3012565) Volume of 24 hour Urine

189

804

1.56

7.36

1.8

2.3

1955.1

1990.9

0.18

173

724

(3017958) Strawberry IgE Ab [Units/volume] in Serum

3.68

7.23

1.0

u/ml

0.1

0.29

(1761482) Bacteria [#/volume] in Urine by Culture

448

3878

0.76

7.21

4.9

3.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

111

414

1.78

7.13

1.2

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

4.77

7.07

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

687

5634

0.80

7.06

1.5

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

511

2614

1.30

7.05

3.2

2.9

nmol/l

0.8

0.20

392

2027

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

292

1.93

7.04

1.7

1.6

—

(3005033) Fetal Nuchal fold Thickness US

687

5621

0.81

6.92

1.5

1.4

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

195

2.14

6.89

1.7

1.9

pmol/l

55.2

52.2

0.08

172

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

4.34

6.74

1.1

1.7

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

138

2.35

6.68

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

708

5746

0.81

6.62

1.5

—

(3001556) Androgen free Index in Serum or Plasma

208

2.07

6.56

1.4

1.2

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

230

1048

1.46

6.53

1.5

1.4

u/l

12.4

12.5

0.11

222

1015

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

165

702

1.56

6.49

1.5

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

358

1763

1.35

6.49

1.3

1.4

mmol/l

11.2

12.0

0.65

102

367

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

200

888

1.49

6.47

1.7

1.8

u/field

1.0

2.9

7.25

139

645

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

165

703

1.56

6.45

1.5

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

201

2.08

6.42

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.73

6.40

1.0

1.1

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

239

1103

1.44

6.36

10.5

12.6

mmol/l

0.6

1.35

218

1005

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4833

34376

0.92

6.32

2.9

2.8

ug/l

0.7

0.8

9.80

3095

21414

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.09

6.32

1.2

1.4

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

2.70

6.27

1.7

0.5

0.7

0.44

(3036312) Salmon IgE Ab [Units/volume] in Serum

102

2.53

6.21

1.1

u/ml

1.2

1.8

0.29

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

171

742

1.53

6.18

1.7

1.5

iu/ml

2034110.0

2374175.9

0.10

(40761539) Cells [Type] in Urine sediment by Light microscopy

359

1.77

6.18

1.2

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

3.19

6.17

1.1

1.0

u/ml

0.5

0.1

0.73

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

115

2.42

6.11

1.0

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

251

1.93

6.10

1.2

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

247

1.93

6.05

1.2

mg/l

0.5

61.8

1.42

177

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

3.93

6.01

1.0

u/ml

0.4

0.8

0.30

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

121

487

1.65

6.00

2.5

3.0

umol/l

28.2

29.2

0.34

375

(3007463) Buprenorphine [Presence] in Urine

3.18

5.93

7.5

6.7

—

(3040151) Glucose [Moles/volume] in Capillary blood

354

1771

1.33

5.82

4.6

10.2

mmol/l

7.2

7.3

0.29

282

1440

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

222

1029

1.43

5.82

1.4

mmol/l

5.6

0.41

209

980

(3007542) Rye IgE Ab [Units/volume] in Serum

2.62

5.80

1.1

1.0

u/ml

0.6

0.7

0.05

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

527

2779

1.26

5.79

1.4

1.3

mmol/l

7.1

0.05

396

1965

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

158

685

1.53

5.77

2.6

2.5

umol/l

54.8

53.3

0.20

124

584

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

3.07

5.60

1.1

u/l

288.2

431.3

0.66

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

217

1.95

5.60

2.5

2.7

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.60

5.57

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.56

5.56

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

228

1072

1.41

5.55

5.7

7.1

—

(3007700) Barley IgE Ab [Units/volume] in Serum

2.67

5.49

1.0

u/ml

0.6

0.9

0.19

(3028717) Thiamine [Mass/volume] in Blood

130

2.24

5.46

1.1

1.2

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

230

1.90

5.35

1.1

1.0

ug/l

80.3

82.4

0.13

190

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

2.58

5.35

1.4

1.5

30.8

39.1

0.44

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.87

5.25

1.2

1.1

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.87

5.25

1.7

1.5

u/l

0.4

0.1

—

(21494434) Karyotype in Bone marrow

262

1274

1.36

5.25

1.2

1.1

—

(3045142) Bone marrow Pathology biopsy report

336

1696

1.31

5.24

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1898

11253

1.12

5.24

1.6

—

(40759632) Porphyrins [Mass/mass] in Stool

5.30

5.24

1.1

1.3

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

3.00

5.21

1.1

u/ml

0.2

0.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

3.49

5.18

1.9

1.1

—

(3033942) Copper [Moles/time] in 24 hour Urine

2.73

5.18

1.1

1.3

umol/24h

0.2

0.8

0.99

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

215

1.91

5.12

1.2

1.1

—

(3019977) pH of Arterial blood

164

737

1.48

5.11

2.5

2.4

7.4

0.81

276

(3044242) Glucose [Moles/volume] in Arterial blood

148

652

1.50

5.08

2.2

2.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

398

3333

0.79

5.07

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

254

1237

1.36

5.06

1.0

1.1

u/ml

0.5

3.1

2.70

333

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

640

3502

1.21

5.06

2.2

2.0

nmol/l

0.9

0.8

1.93

517

2956

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

275

1.78

4.95

1.1

1.2

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

150

2.08

4.88

1.4

1.5

ug/l

129.5

121.6

0.16

121

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

267

1.79

4.86

1.2

1.3

ng/l

95.9

94.5

0.01

172

(3051101) Glucose [Moles/volume] in Cord blood

322

0.35

4.85

3.6

6.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

230

1.84

4.78

1.2

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

147

2.07

4.77

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

121

2.19

4.75

1.3

1.4

—

11.9

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

5.20

4.72

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

679

0.55

4.72

2.8

3.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

678

0.56

4.69

5.6

6.5

—

(3004451) EKG impression Narrative

141

627

1.49

4.67

1.4

1.2

—

(3022689) Creatine [Moles/volume] in Urine

115

490

1.56

4.63

1.3

1.4

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

3.82

4.61

1.0

2.7

2.5

0.12

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.45

4.57

1.0

—

(3016031) Almond IgE Ab [Units/volume] in Serum

119

2.17

4.55

1.1

1.0

u/ml

0.2

0.9

2.68

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

169

1.96

4.49

1.2

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.35

4.48

1.0

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

117

506

1.53

4.43

1.4

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.36

4.37

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

512

4102

0.82

4.37

1.5

1.6

—

(3009883) Potato IgE Ab [Units/volume] in Serum

4.10

4.35

1.0

u/ml

0.8

0.3

—

(3017509) Phencyclidine [Presence] in Urine

233

1.79

4.33

1.6

1.8

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.72

4.28

1.2

1.3

nmol/l

417.9

662.1

1.52

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

396

1.59

4.24

2.4

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

396

1.59

4.24

2.4

2.3

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

3.55

4.20

1.0

1.1

—

(3038515) Glucose [Moles/volume] in Venous blood

349

2895

0.80

4.18

3.6

2.8

mmol/l

7.1

7.7

4.65

340

2843

(3017937) Magnesium [Moles/time] in 24 hour Urine

3.22

4.15

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

245

1228

1.32

4.12

1.1

u/ml

4.4

7.7

0.37

299

(21494814) CD8 cells/100 lymphocytes in Specimen

140

639

1.45

4.12

2.0

1.9

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

130

585

1.47

4.11

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

189

1.86

4.11

2.2

2.6

pmol/l

44.8

81.8

1.38

167

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

103

2.19

4.07

3.4

2.3

—

(3004775) Volume in Urine collected for unspecified duration

152

1407

0.71

4.05

2.3

766.7

675.0

1.76

112

988

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

122

2.06

3.95

1.1

1.0

u/ml

1.1

0.5

0.25

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

4.73

3.91

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

4.73

3.91

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

4.73

3.91

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

4.73

3.91

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

4.73

3.91

2.0

1.9

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

4.73

3.91

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

141

653

1.43

3.87

3.7

4.0

—

(40768793) Breast Pathology biopsy report

702

3977

1.17

3.87

1.3

—

(40757373) Influenza virus identified in Isolate

268

1.68

3.81

1.6

1.5

—

(3017569) Oxygen content in Arterial blood

139

645

1.43

3.79

2.3

2.2

—

(3025315) Body weight

143

1.95

3.75

4.7

3.9

—

(3020618) Glucose [Moles/volume] in Synovial fluid

2.80

3.73

1.0

1.1

mmol/l

5.4

5.2

0.07

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

197

972

1.34

3.73

1.0

ng/l

293.9

337.1

1.48

151

716

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.62

3.69

1.0

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

144

1.93

3.69

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

120

1135

0.70

3.67

1.5

1.3

—

(40768446) Kidney Pathology biopsy report

153

728

1.39

3.64

1.7

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

197

978

1.34

3.60

1.0

ng/l

46.6

42.3

0.18

148

709

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

197

978

1.34

3.60

1.0

ng/l

851.9

714.0

3.55

147

688

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

2.23

3.56

1.1

1.0

mmol/l

8.7

8.6

0.14

(3004446) Plasmodium sp identified in Blood by Light microscopy

194

1.78

3.55

2.8

2.6

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

254

1.67

3.52

2.6

6.9

u/l

70.2

43.0

0.88

120

(3006270) Folate [Moles/volume] in Blood

254

1311

1.28

3.52

1.2

1.1

nmol/l

370.0

379.9

0.31

228

1108

(40762887) Creatinine [Moles/volume] in Blood

3.44

3.51

1.2

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

3.44

3.51

1.2

nmol/24h

74.2

110.8

0.93

(3051593) INR in Capillary blood by Coagulation assay

141

667

1.40

3.49

7.0

10.9

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

215

1.73

3.48

1.8

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

404

2202

1.22

3.47

2.4

2.5

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

499

2775

1.19

3.47

3.4

3.6

u/ml

27.0

38.2

2.11

482

2677

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

3.61

3.45

1.1

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.16

3.41

1.4

1.3

umol/24h

331.6

294.6

0.46

(3025886) Oxalate [Mass/time] in 24 hour Urine

3.01

3.34

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

203

1.73

3.33

1.0

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.13

3.33

2.0

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

316

1.57

3.29

1.2

1.5

nmol/l

5.2

5.8

0.83

303

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

227

1168

1.29

3.25

1.5

—

(3008037) Lactate [Moles/volume] in Venous blood

385

3066

0.83

3.20

3.4

2.7

mmol/l

1.4

1.6

5.79

375

2998

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

800

0.67

3.19

2.3

2.4

nmol/l

139.4

154.0

0.67

685

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

304

1.57

3.15

5.5

6.8

64.1

71.2

1.18

242

(3015076) Soybean IgE Ab [Units/volume] in Serum

218

1123

1.29

3.11

1.0

u/ml

0.3

0.6

0.89

143

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

183

921

1.32

3.11

1.7

2.0

—

(3012441) Differential panel - Pleural fluid

291

1558

1.24

3.02

1.6

1.5

—

(3021661) Pineapple IgE Ab [Units/volume] in Serum

3.47

3.01

1.1

1.0

u/ml

0.1

0.5

—

(3044007) Cell count panel - Peritoneal fluid

409

1.47

3.01

2.7

1.7

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

152

1.79

2.91

1.2

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

2.56

2.89

5.2

5.8

mmol/l

0.3

0.2

0.76

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

2.21

2.89

1.0

1.1

u/l

1.6

4.0

—

(3051339) Copper [Moles/volume] in Blood

2.21

2.89

1.2

1.4

umol/l

16.9

16.5

0.13

(3020393) Adenovirus Ag [Presence] in Stool

153

1.77

2.86

1.4

1.2

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

297

1.54

2.82

1.3

g/l

117.1

26.5

0.50

241

(3017461) Flecainide [Moles/volume] in Serum or Plasma

2.05

2.75

1.4

1.9

umol/l

0.7

0.6

0.38

(3033799) Differential panel - Peritoneal fluid

424

1.44

2.72

2.0

1.7

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.61

2.67

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

165

840

1.30

2.64

1.4

1.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

449

1.42

2.63

2.1

1.7

e6/l

13001.0

17647.9

0.24

233

(3015350) Toxocara sp Ab [Presence] in Serum

3.97

2.63

1.0

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

109

1.88

2.62

1.9

3.4

pmol/l

19.1

104.6

0.89

(3035933) Granulocytes/100 leukocytes in Blood

111

533

1.38

2.62

1.4

1.7

—

(3045788) Cell count panel - Pleural fluid

261

1407

1.23

2.60

1.7

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

166

848

1.30

2.60

1.4

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

182

944

1.28

2.54

1.4

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

221

1.59

2.51

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

237

1.56

2.50

1.5

1.6

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

176

1.66

2.46

1.3

56.7

53.5

0.14

(3048879) Bone marrow aspiration report

417

1.41

2.44

1.7

1.8

—

(44806420)

430

0.62

2.42

1.9

2.4

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

252

0.50

2.42

5.4

7.5

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

152

1.70

2.40

2.2

2.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

108

1.84

2.39

1.8

1.4

—

(3006576) Bicarbonate [Moles/volume] in Blood

112

548

1.35

2.39

6.2

6.4

mmol/l

25.4

25.1

0.20

106

487

(3000012) Reticulocyte production index

167

865

1.28

2.38

1.4

1.6

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

209

1.58

2.37

5.9

9.7

umol/l

0.3

0.4

0.63

189

(3007919) Fasciola sp Ab [Titer] in Serum

2.91

2.36

1.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

2.91

2.36

2.0

1.3

mmol/24h

2.3

2.0

0.38

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

2.74

2.33

1.3

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

322

1794

1.19

2.33

1.6

mmol/l

7.8

7.4

2.00

203

1025

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

1.96

2.30

1.0

1.1

u/field

1.4

1.2

0.14

(3051387) C reactive protein [Mass/volume] in Capillary blood

527

3973

0.88

2.30

3.8

2.7

mg/l

23.3

28.0

2.15

274

2527

(3002814) Trichinella spiralis Ab [Titer] in Serum

3.78

2.30

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.25

2.28

1.0

1.1

nmol/l

335.8

233.9

1.03

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

106

519

1.35

2.27

2.2

1.8

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

105

514

1.35

2.25

2.3

1.7

e6/l

10694.7

1758.2

0.53

349

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.86

2.25

1.3

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

321

1795

1.19

2.24

1.6

1.5

e6/l

5908.5

3542.3

0.60

218

1312

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

925

6727

0.91

2.16

1.4

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

3.53

2.16

1.0

1.2

nmol/l

273.9

263.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

923

6711

0.91

2.15

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

189

1.58

2.12

2.1

1.9

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

928

6738

0.91

2.11

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

929

6739

0.91

2.08

1.4

—

(3049242) von Willebrand panel - Platelet poor plasma

2.26

2.04

1.5

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

2.03

2.02

7.3

6.0

mmol/l

16.2

17.2

0.42

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

2.98

2.01

1.0

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

130

1.68

2.00

1.1

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

233

1847

0.83

2.00

1.4

1.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

321

1817

1.17

1.99

1.4

1.3

pmol/l

67.1

121.0

0.57

126

538

(3028308) Erythrocytes [#/volume] in Pleural fluid

292

1641

1.18

1.97

1.6

1.5

e6/l

50185.9

55202.8

0.11

167

991

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

101

1.77

1.95

1.2

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

111

1.73

1.95

6.0

4.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

140

731

1.27

1.94

1.1

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

235

1299

1.20

1.92

1.8

2.0

u/field

2.2

2.4

0.20

128

545

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

189

1.54

1.92

1.2

1.4

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

2.84

1.91

1.2

1.3

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

2.84

1.91

1.2

1.3

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

243

1.47

1.90

5.1

4.8

ug/min

68.3

42.8

1.06

192

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

363

2083

1.16

1.90

1.2

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

145

763

1.26

1.90

1.1

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

528

0.70

1.87

1.2

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

4.73

1.86

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

198

1579

0.83

1.84

2.7

2.1

—

(40765096) Chromosome analysis panel by Banding

453

1.33

1.82

1.1

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.76

1.80

1.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

996

7146

0.92

1.79

1.5

—

(3042733) HLA Ab [Presence] in Serum

117

605

1.28

1.78

5.6

5.0

—

(4133840)

107

547

1.30

1.78

1.1

1.2

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

3.61

1.76

1.2

2.8

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

110

1.69

1.75

2.0

2.7

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

110

1.69

1.75

1.3

1.2

ug/l

88.5

134.6

1.19

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.91

1.74

10.9

8.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

276

1.42

1.73

1.8

2.7

mmol/l

7.4

0.00

145

(3032352) Blasts [#/volume] in Cerebral spinal fluid

157

1.56

1.72

1.5

2.3

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

1.87

1.72

1.2

1.9

ng/l

270.1

201.0

0.39

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

131

1.62

1.72

1.0

1.1

u/ml

3.5

11.2

2.64

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

4.14

1.70

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.75

1.69

1.5

1.9

—

(40768806) Pleura Pathology biopsy report

277

1575

1.17

1.68

1.5

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

107

1.67

1.65

1.9

1.4

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.71

1.64

1.1

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

123

1.61

1.62

1.3

ml/s/173m2

1.0

1.2

0.43

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

203

1.47

1.61

2.3

2.6

u/field

0.4

0.5

0.51

203

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

1.91

1.57

1.1

1.0

u/ml

0.2

—

(3014891) Appearance of Pleural fluid

188

1.48

1.57

1.5

1.6

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

3.68

1.55

2.2

1.1

—

(4281824)

307

1772

1.15

1.55

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

209

1171

1.18

1.54

1.7

2.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.10

1.54

1.1

1.0

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

2.10

1.54

5.8

5.7

mg/l

6.8

5.6

—

(3018291) Platelet Ab [Presence] in Serum

2.36

1.52

1.0

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

3.06

1.52

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

290

1.37

1.50

4.2

6.5

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

2.48

1.48

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

247

1.39

1.45

1.2

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.69

1.43

1.1

1.2

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

3.31

1.43

1.4

1.0

—

(3044316) Mercury [Moles/volume] in Urine

0.00

1.38

0.0

1.8

—

11.6

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

113

1.58

1.38

1.1

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

113

1.58

1.38

3.4

4.7

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

467

0.74

1.38

1.4

1.3

3.8

2.7

0.30

393

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.93

1.36

2.6

3.1

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

3.01

1.31

1.4

1.3

—

(3009677) Dengue virus Ab [Presence] in Serum

1.66

1.28

1.0

1.1

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.30

1.26

1.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1835

12728

0.95

1.25

1.5

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.14

1.25

1.0

1.1

—

(3016750) Collection duration of Urine

131

1038

0.83

1.24

2.3

2.1

min

505.6

500.8

0.22

101

797

(3001218) Citrate [Mass/time] in 24 hour Urine

2.48

1.23

2.0

1.3

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

2.48

1.23

1.0

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

340

2014

1.12

1.21

1.5

1.4

g/l

32.7

33.8

0.85

300

1822

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

167

1.43

1.18

3.4

3.1

mg/l

1.1

1.3

0.22

110

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

156

1.44

1.18

1.1

u/l

21.2

20.5

0.10

103

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

235

1.35

1.17

1.3

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

207

1.38

1.16

2.5

2.3

mmol/l

1.2

1.5

0.55

148

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.60

1.15

1.0

1.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

541

0.78

1.14

1.4

1.3

54.3

59.9

0.61

446

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.89

1.12

1.0

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.83

1.11

1.2

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.04

1.11

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

313

1.29

1.10

2.4

2.9

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

227

1.34

1.08

1.7

3.3

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

228

1.34

1.06

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.58

1.05

1.1

1.0

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

416

1.24

1.04

1.9

2.6

ng/l

115.6

103.9

0.23

239

(3027696) Helicobacter pylori Ab [Titer] in Serum

2.11

1.03

1.0

1.1

titre

1211.4

2164.1

—

(3032641) Amino acids panel - Urine

2.11

1.03

1.0

1.2

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.57

1.00

1.2

1.5

1.4

0.34

(3046904) Somatotropin [Units/volume] in Serum or Plasma

1.86

0.99

1.0

3.2

mu/l

4.6

1.8

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

135

1.42

0.97

2.9

4.2

mg/l

2.2

2.3

0.08

114

(3010937) Rubella virus Ab [Presence] in Serum

113

1.46

0.97

1.0

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

302

1.27

0.96

1.4

1.7

ug/l

2.4

2.9

0.23

193

(37019676) Renin [Units/volume] in Plasma --supine

1.89

0.95

1.1

mu/l

24.0

87.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

191

1431

0.88

0.94

1.3

g/l

1.5

0.06

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

143

1.39

0.90

1.1

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

1.50

0.89

14.1

8.6

e6/l

244.3

324.7

0.17

(36303858) Crystals [Presence] in Urine

2.09

0.89

1.2

1.1

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.89

0.88

1.0

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

1.52

0.87

1.0

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

133

1.39

0.86

1.1

1.2

—

(4212803)

139

1.38

0.85

1.1

1.0

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

291

1.25

0.83

2.6

2.5

mg/l

37.0

41.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.73

0.83

8.2

9.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

304

1.24

0.81

2.1

2.3

—

(3024316) Viscosity of Plasma

1.55

0.77

1.3

1.6

mpas

1.5

1.7

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

116

0.63

0.76

1.1

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.93

0.76

1.1

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.59

0.75

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

429

1.19

0.74

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

692

4836

0.95

0.74

1.4

—

(3020650) Glucose [Presence] in Urine

509

1.17

0.73

1.4

1.3

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

161

1.32

0.73

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.42

0.71

6.1

5.8

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.70

0.71

1.4

1.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

167

989

1.12

0.71

5.7

6.5

u/ml

1115.7

4523.9

0.57

224

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

1.50

0.69

1.0

u/ml

0.0

0.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

105

796

0.87

0.68

1.0

—

(3000285) Sodium [Moles/volume] in Blood

175

1.29

0.67

1.1

—

(3022475) Manganese [Moles/volume] in Blood

101

1.38

0.64

1.3

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

226

1372

1.09

0.62

1.4

1.3

u/l

450.0

578.2

0.86

211

1302

(3029612) Listeria sp Ab [Titer] in Serum

1.60

0.61

1.6

1.2

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

1.44

0.58

1.4

1.6

2.4

2.6

0.09

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.65

0.56

1.0

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

651

4115

1.05

0.55

2.3

2.4

ug/min

128.1

101.3

0.70

388

2521

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.42

0.55

1.1

1.5

u/field

1.1

1.2

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

163

1.26

0.55

1.3

1.2

u/l

82.8

60.3

0.25

113

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

193

1.23

0.54

5.9

3.5

umol/l

38.8

41.9

0.32

172

(40763791) Oxygen content in Venous blood by calculation

1.49

0.54

8.0

9.3

ml/dl

13.8

10.7

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.52

0.54

1.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

208

1272

1.08

0.51

1.3

1.2

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

202

0.79

0.51

1.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

236

1454

1.07

0.49

1.4

1.3

mmol/l

6.3

6.1

0.29

218

1337

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

816

5603

0.96

0.48

1.8

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

1.38

0.46

1.1

1.0

u/ml

0.1

0.4

—

(3034614) HLA Ag [Interpretation]

1.47

0.44

1.0

1.2

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

124

0.75

0.44

2.9

2.0

47.1

57.9

—

(3024471) HLA-A [Type]

105

628

1.11

0.44

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

131

0.76

0.43

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

513

3254

1.04

0.42

1.3

ug/l

3.6

3.9

0.13

445

2976

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.36

0.41

1.4

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

110

1.26

0.41

1.0

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.34

0.38

2.5

3.5

—

(3041806) Other cells [#/volume] in Blood by Manual count

158

1119

0.93

0.35

1.6

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

949

6118

1.03

0.34

1.5

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1290

8350

1.02

0.34

1.5

1.4

—

(3003577) Lead [Moles/volume] in Blood

168

1.18

0.34

1.5

1.4

umol/l

0.2

0.22

(21494567) Legionella sp IgM Ab [Presence] in Serum

114

1.22

0.32

1.0

1.1

—

(40760409) HLA-A [Type] by High resolution

0.70

0.31

1.0

—

(3013862) HLA-DP [Type]

0.70

0.31

1.0

—

(40760410) HLA-B [Type] by High resolution

0.70

0.31

1.0

—

(40763590) HLA-DQ beta [Type]

0.69

0.31

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.69

0.31

1.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.32

0.31

8.1

2.6

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

121

1.20

0.30

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.30

0.30

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

171

1.16

0.29

1.5

1.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

118

729

1.07

0.29

3.1

3.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

126

890

0.94

0.28

1.1

—

(3035880) pH of Pleural fluid

118

835

0.94

0.28

1.3

1.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

228

0.87

0.27

1.2

1.4

9.4

13.6

—

117

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.23

0.27

1.0

1.1

mmol/l

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.27

0.27

2.6

3.6

—

(3024932) HLA-DR beta [Type]

611

1.07

0.26

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.20

0.25

1.1

1.0

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

369

1.09

0.25

1.5

1.3

g/l

13.7

13.3

0.14

285

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

155

1.15

0.25

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

308

1967

1.04

0.24

1.6

1.9

ug/l

24.5

24.9

0.03

303

1928

(3006598) pH of Arterial cord blood

0.81

0.23

1.0

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

270

1.10

0.22

1.3

1.2

mmol/l

1.9

1.7

0.34

160

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

0.00

0.22

0.0

3.3

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.27

0.22

1.0

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

175

1108

1.05

0.21

1.3

u/l

16.2

14.8

0.32

159

1028

(4038314)

181

0.88

0.21

1.3

1.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

207

1317

1.04

0.21

1.4

nmol/l

28.2

32.6

1.41

182

1234

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

361

1.08

0.20

1.5

1.3

26.4

23.4

0.31

303

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.80

0.20

2.0

—

(3013762) Body weight Measured

1.20

0.20

1.1

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

173

0.88

0.20

1.5

1.4

67.2

71.5

0.20

144

(3023383) Lactate [Moles/volume] in Pleural fluid

452

1.07

0.19

1.3

mmol/l

3.2

3.6

0.58

418

(3022670) pH of Venous cord blood

1.22

0.18

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

379

1.07

0.16

7.9

7.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

289

1.08

0.16

7.8

7.0

—

(40768795) Lymph node Pathology biopsy report

279

1800

1.03

0.15

1.2

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.83

0.14

1.0

—

(44786800) Granulocytes/100 leukocytes in Body fluid

176

1.09

0.13

1.4

1.3

37.0

24.0

0.97

135

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

461

1.05

0.12

1.7

2.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.86

0.11

1.3

1.2

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.14

0.10

2.0

2.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

158

0.92

0.09

1.0

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.10

0.08

3.7

6.6

—

(3047185) IgG [Mass/volume] in Urine

1.03

0.08

1.0

1.1

—

49.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

419

0.96

0.08

1.3

ug/l

345.8

278.4

0.08

232

(3003157) Bacteria [#/volume] in Mother's milk

0.83

0.08

3.5

7.3

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.04

0.07

1.9

2.1

—

(40758358) Immune stain study

1.10

0.06

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

127

0.94

0.05

1.2

1.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

103

669

1.02

0.05

2.8

3.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.08

0.04

1.0

—

(40758292) HTLV I+II Ab panel - Serum

320

0.97

0.04

1.4

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

173

0.96

0.04

1.2

mmol/l

20.0

20.9

0.49

129

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

436

1.02

0.02

7.7

7.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

212

1393

1.01

0.02

1.1

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.06

0.02

3.2

3.7

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.01

0.00

8.1

8.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

209

1.01

0.00

1.3

1.2

mmol/l

0.9

1.3

0.34

130

(3034092) Cytoplasmic Ig cells/100 cells in Blood

282

1.01

0.00

12.0

7.2

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.99

0.00

1.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.95

0.00

1.4

1.0

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.0

1.2

—

(3026820) Hemoglobin [Mass/volume] in Venous cord blood

0.00

0.0

1.0

—

162.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.01

0.00

1.4

1.2

—

(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid

0.00

0.0

7.8

—

Mortality – FinRegistry

↥

Association

Association between endpoint JOINTPAIN and mortality.

Females

Parameter	HR [95% CI]	p-value
JOINTPAIN	1.012 [0.92, 1.12]	0.802
Birth year	0.994 [0.99, 1.0]	0.156

During the follow-up period (1.1.1998 — 31.12.2019), 9175 out of 134317 females with JOINTPAIN died.

Males

Parameter	HR [95% CI]	p-value
JOINTPAIN	1.072 [0.98, 1.18]	0.144
Birth year	0.985 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 7423 out of 83247 males with JOINTPAIN died.

Mortality risk

Mortality risk for people of age

years, who have JOINTPAIN.

N-year risk	Females	Males
1	0.094%	0.193%
5	0.508%	1.113%
10	1.386%	3.032%
15	2.836%	5.925%
20	4.971%	9.673%

Relationships between endpoints

↥

Index endpoint: JOINTPAIN – Pain in joint

GWS hits: 9

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Pain in joint

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints